Publications: Prof David Baker
Mout R, Bretherton RC, Decarreau J, Lee S, Gregorio N, Edman NI, Ahlrichs M, Hsia Y et al.
(
2024
)
.
De novo design of modular protein hydrogels with programmable intra- and extracellular viscoelasticity
.
Proceedings of the National Academy of Sciences of the United States of America
vol.
121
,
(
6
)
Zhang JZ, Nguyen WH, Greenwood N, Rose JC, Ong S-E, Maly DJ, Baker D
(
2024
)
.
Computationally designed sensors detect endogenous Ras activity and signaling effectors at subcellular resolution
.
Nature Biotechnology1
-
11
.
Baker D, Church G
(
2024
)
.
Protein design meets biosecurity
.
Science
vol.
383
,
(
6681
)
349
-
349
.
Sumida KH, Núñez-Franco R, Kalvet I, Pellock SJ, Wicky BIM, Milles LF, Dauparas J, Wang J et al.
(
2024
)
.
Improving Protein Expression, Stability, and Function with ProteinMPNN
.
Journal of the American Chemical Society
vol.
146
,
(
3
)
2054
-
2061
.
Baker D, Kang AS, Giovannoni G, Schmierer K
(
2023
)
.
Neutropenia following immune-depletion, notably CD20 targeting, therapies in multiple sclerosis
.
Multiple Sclerosis and Related Disorders
vol.
82
,
Vázquez Torres S, Leung PJY, Venkatesh P, Lutz ID, Hink F, Huynh H-H, Becker J, Yeh AH-W et al.
(
2023
)
.
De novo design of high-affinity binders of bioactive helical peptides
.
Nature
vol.
626
,
(
7998
)
435
-
442
.
Stoakes E, Turner K, Baker DJ, Suau Sans M, Yasir M, Kalmar L, Costigan R, Lott M et al.
(
2023
)
.
Application of TraDIS to define the core essential genome of Campylobacter jejuni and Campylobacter coli
.
BMC Microbiology
vol.
23
,
(
1
)
Roy A, Shi L, Chang A, Dong X, Fernandez A, Kraft JC, Li J, Le VQ et al.
(
2023
)
.
De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8
.
Nature Communications
vol.
14
,
(
1
)
Davila-Hernandez FA, Jin B, Pyles H, Zhang S, Wang Z, Huddy TF, Bera AK, Kang A et al.
(
2023
)
.
Directing polymorph specific calcium carbonate formation with de novo protein templates
.
Nature Communications
vol.
14
,
(
1
)
Bennett NR, Coventry B, Goreshnik I, Huang B, Allen A, Vafeados D, Peng YP, Dauparas J et al.
(
2023
)
.
Improving de novo protein binder design with deep learning
.
Nature Communications
vol.
14
,
(
1
)
Hutchinson GB, Abiona OM, Ziwawo CT, Werner AP, Ellis D, Tsybovsky Y, Leist SR, Palandjian C et al.
(
2023
)
.
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera
.
Nature Communications
vol.
14
,
(
1
)
Nieweglowska ES, Brilot AF, Méndez-Moran M, Kokontis C, Baek M, Li J, Cheng Y, Baker D et al.
(
2023
)
.
The ϕPA3 phage nucleus is enclosed by a self-assembling 2D crystalline lattice
.
Nature Communications
vol.
14
,
(
1
)
Allen-Philbey K, De Trane S, MacDougall A, Adams A, Bianchi L, Campion T, Giovannoni G, Gnanapavan S et al.
(
2023
)
.
Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis
.
Therapeutic Advances in Neurological Disorders
vol.
16
,
Goldbach N, Benna I, Wicky BIM, Croft JT, Carter L, Bera AK, Nguyen H, Kang A et al.
(
2023
)
.
De novo design of monomeric helical bundles for pH-controlled membrane lysis
.
Protein Science
vol.
32
,
(
11
)
Mansoor S, Baek M, Juergens D, Watson JL, Baker D
(
2023
)
.
Zero-shot mutation effect prediction on protein stability and function using RoseTTAFold
.
Protein Science
vol.
32
,
(
11
)
Alghadeer A, Hanson-Drury S, Patni AP, Ehnes DD, Zhao YT, Li Z, Phal A, Vincent T et al.
(
2023
)
.
Single-cell census of human tooth development enables generation of human enamel
.
Developmental Cell
vol.
58
,
(
20
)
2163
-
2180.e9
.
Baker D
(
2023
)
.
Proteomic interrogation of the meninges reveals the molecular identities of structural components and regional distinctions along the CNS axis
.
Fluids and Barriers of the CNS
Watson JL, Krüger LK, Ben-Sasson AJ, Bittleston A, Shahbazi MN, Planelles-Herrero VJ, Chambers JE, Manton JD et al.
(
2023
)
.
Synthetic Par polarity induces cytoskeleton asymmetry in unpolarized mammalian cells
.
Cell
vol.
186
,
(
21
)
4710
-
4727.e35
.
Dubuisson N, de Maere d'Aertrijcke O, Marta M, Gnanapavan S, Turner B, Baker D, Schmierer K, Giovannoni G et al.
(
2023
)
.
Anaesthetic management of people with multiple sclerosis
.
Multiple Sclerosis and Related Disorders
vol.
80
,
Seaton A, Baker D, Hedstrom AK, Alfredsson L, Schmierer K
(
2023
)
.
Organic solvents and Multiple Sclerosis: the doubled risk dilemma
.
Occupational Medicine
vol.
73
,
(
6
)
300
-
303
.
Watson JL, Juergens D, Bennett NR, Trippe BL, Yim J, Eisenach HE, Ahern W, Borst AJ et al.
(
2023
)
.
De novo design of protein structure and function with RFdiffusion
.
Nature
vol.
620
,
(
7976
)
1089
-
1100
.
Praetorius F, Leung PJY, Tessmer MH, Broerman A, Demakis C, Dishman AF, Pillai A, Idris A et al.
(
2023
)
.
Design of stimulus-responsive two-state hinge proteins
.
Science
vol.
381
,
(
6659
)
754
-
760
.
Dobson R
(
2023
)
.
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination
.
Multiple Sclerosis Journal
Baker D
(
2023
)
.
Neuroprotection in an
Experimental Model of Multiple
Sclerosis via Opening of Big
Conductance, Calcium-Activated
Potassium Channels
.
Pharmaceuticals
vol.
16
,
972
-
972
.
van Noort JM, Baker D, Kipp M, Amor S
(
2023
)
.
The pathogenesis of multiple sclerosis: a series of unfortunate events
.
Clinical & Experimental Immunology
vol.
214
,
(
1
)
1
-
17
.
Kalvet I, Ortmayer M, Zhao J, Crawshaw R, Ennist NM, Levy C, Roy A, Green AP et al.
(
2023
)
.
Design of Heme Enzymes with a Tunable Substrate Binding Pocket Adjacent to an Open Metal Coordination Site
.
Journal of the American Chemical Society
vol.
145
,
(
26
)
14307
-
14315
.
Lin D, Li X, Moult E, Park P, Tang B, Shen H, Grimm JB, Falco N et al.
(
2023
)
.
Time-tagged ticker tapes for intracellular recordings
.
Nature Biotechnology
vol.
41
,
(
5
)
631
-
639
.
Watson PR, Gupta S, Hosseinzadeh P, Brown BP, Baker D, Christianson DW
(
2023
)
.
Macrocyclic Octapeptide Binding and Inferences on Protein Substrate Binding to Histone Deacetylase 6
.
ACS Chemical Biology
vol.
18
,
(
4
)
959
-
968
.
Lutz ID, Wang S, Norn C, Courbet A, Borst AJ, Zhao YT, Dosey A, Cao L et al.
(
2023
)
.
Top-down design of protein architectures with reinforcement learning
.
Science (New York, N.Y.)
vol.
380
,
(
6642
)
266
-
273
.
Wu K, Bai H, Chang YT, Redler R, McNally KE, Sheffler W, Brunette TJ, Hicks DR et al.
(
2023
)
.
De novo design of modular peptide-binding proteins by superhelical matching
.
Nature
vol.
616
,
(
7957
)
581
-
589
.
Patrick K, Tian X, Cartwright D, Heising S, Glover MS, Northall EN, Cazares L, Hess S et al.
(
2023
)
.
Sex-specific effects of CD248 on metabolism and the adipose tissue lipidome
.
PLoS ONE
vol.
18
,
(
4 April
)
d'Amone L, Matzeu G, Quijano-Rubio A, Callahan GP, Napier B, Baker D, Omenetto FG
(
2023
)
.
Reshaping de Novo Protein Switches into Bioresponsive Materials for Biomarker, Toxin, and Viral Detection
.
Advanced Materials
vol.
35
,
(
11
)
Kim DE, Jensen DR, Feldman D, Tischer D, Saleem A, Chow CM, Li X, Carter L et al.
(
2023
)
.
De novo design of small beta barrel proteins
.
Proceedings of the National Academy of Sciences of the United States of America
vol.
120
,
(
11
)
Wang JY, Khmelinskaia A, Sheffler W, Miranda MC, Antanasijevic A, Borst AJ, Torres SV, Shu C et al.
(
2023
)
.
Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains
.
Proceedings of the National Academy of Sciences of the United States of America
vol.
120
,
(
11
)
James SA, Telatin A, Baker D, Evans R, Clarke P, Hall LJ, Carding SR
(
2023
)
.
Draft Genome Sequence of a Preterm Infant-Derived Isolate of Candida parapsilosis
.
Microbiology Resource Announcements
vol.
12
,
(
3
)
Motmaen A, Dauparas J, Baek M, Abedi MH, Baker D, Bradley P
(
2023
)
.
Peptide-binding specificity prediction using fine-tuned protein structure prediction networks
.
Proceedings of the National Academy of Sciences of the United States of America
vol.
120
,
(
9
)
Yeh AHW, Norn C, Kipnis Y, Tischer D, Pellock SJ, Evans D, Ma P, Lee GR et al.
(
2023
)
.
De novo design of luciferases using deep learning
.
Nature
vol.
614
,
(
7949
)
774
-
780
.
Wang X, Guillem JM, Lee D, Hinck A, Beth R, Baker D
(
2023
)
.
De novo design of BMP mimics
.
Biophysical journal
vol.
122
,
(
3S1
)
Gerben SR, Borst AJ, Hicks DR, Moczygemba I, Feldman D, Coventry B, Yang W, Bera AK et al.
(
2023
)
.
Design of Diverse Asymmetric Pockets in De Novo Homo-oligomeric Proteins
.
Biochemistry
vol.
62
,
(
2
)
358
-
368
.
Li Z, Wang S, Nattermann U, Bera AK, Borst AJ, Yaman MY, Bick MJ, Yang EC et al.
(
2023
)
.
Accurate computational design of three-dimensional protein crystals
.
Nature Materials
Baek M, McHugh R, Anishchenko I, Jiang H, Baker D, DiMaio F
(
2023
)
.
Accurate prediction of protein–nucleic acid complexes using RoseTTAFoldNA
.
Nature Methods
Hanson-Drury S, Patni AP, Lee DL, Alghadeer A, Zhao YT, Ehnes DD, Vo VN, Kim SY et al.
(
2023
)
.
Corrigendum: Single cell RNA sequencing reveals human tooth type identity and guides in vitro hiPSC derived odontoblast differentiation (iOB) (Front. Dent. Med, (2023), 4, 1209503, 10.3389/fdmed.2023.1209503)
.
Frontiers in Dental Medicine
vol.
4
,
Yang H, Ulge UY, Quijano-Rubio A, Bernstein ZJ, Maestas DR, Chun JH, Wang W, Lin JX et al.
(
2023
)
.
Design of cell-type-specific hyperstable IL-4 mimetics via modular de novo scaffolds
.
Nature Chemical Biology
Rennella E, Sahtoe DD, Baker D, Kay LE
(
2023
)
.
Exploiting conformational dynamics to modulate the function of designed proteins
.
Proceedings of the National Academy of Sciences of the United States of America
vol.
120
,
(
118
)
Wang Y, Gallagher LA, Andrade PA, Liu A, Humphreys IR, Turkarslan S, Cutler KJ, Arrieta-Ortiz ML et al.
(
2023
)
.
Genetic manipulation of Patescibacteria provides mechanistic insights into microbial dark matter and the epibiotic lifestyle
.
Cell
An L, Hicks DR, Zorine D, Dauparas J, Wicky BIM, Milles LF, Courbet A, Bera AK et al.
(
2023
)
.
Hallucination of closed repeat proteins containing central pockets
.
Nature Structural and Molecular Biology
Olshefsky A, Benasutti H, Sylvestre M, Butterfield GL, Rocklin GJ, Richardson C, Hicks DR, Lajoie MJ et al.
(
2023
)
.
In vivo selection of synthetic nucleocapsids for tissue targeting
.
Proceedings of the National Academy of Sciences of the United States of America
vol.
120
,
(
46
)
Bethel NP, Borst AJ, Parmeggiani F, Bick MJ, Brunette T, Nguyen H, Kang A, Bera AK et al.
(
2023
)
.
Precisely patterned nanofibres made from extendable protein multiplexes
.
Nature Chemistry
Ouberai MM, Gomes Dos Santos AL, Kinna S, Hornigold DC, Baker D, Naylor J, Liang L, Corkill DJ et al.
(
2023
)
.
Self-assembled GLP-1/glucagon peptide nanofibrils prolong inhibition of food intake
.
Frontiers in Endocrinology
vol.
14
,
Hanson-Drury S, Patni AP, Lee DL, Alghadeer A, Zhao YT, Ehnes DD, Vo VN, Kim SY et al.
(
2023
)
.
Single cell RNA sequencing reveals human tooth type identity and guides in vitro hiPSC derived odontoblast differentiation (iOB)
.
Frontiers in Dental Medicine
vol.
4
,
Bermeo S, Favor A, Chang YT, Norris A, Boyken SE, Hsia Y, Haddox HK, Xu C et al.
(
2022
)
.
De novo design of obligate ABC-type heterotrimeric proteins
.
Nature Structural and Molecular Biology
vol.
29
,
(
12
)
1266
-
1276
.
Lewis JE, Woodward OR, Nuzzaci D, Smith CA, Adriaenssens AE, Billing L, Brighton C, Phillips BU et al.
(
2022
)
.
Relaxin/insulin-like family peptide receptor 4 (Rxfp4) expressing hypothalamic neurons modulate food intake and preference in mice
.
Molecular Metabolism
vol.
66
,
Linsky TW, Noble K, Tobin AR, Crow R, Carter L, Urbauer JL, Baker D, Strauch EM
(
2022
)
.
Sampling of structure and sequence space of small protein folds
.
Nature Communications
vol.
13
,
(
1
)
Baker D, Forte E, Pryce G, Kang AS, James LK, Giovannoni G, Schmierer K
(
2022
)
.
The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination
.
Multiple Sclerosis and Related Disorders
vol.
69
,
Baker D, Vainchtein ID
(
2022
)
.
Characterizing microglial gene expression in a model of secondary progressive MS
.
Glia
Licht‐Mayer S, Campbell GR, Mehta AR, McGill K, Symonds A, Al‐Azki S, Pryce G, Zandee S et al.
(
2022
)
.
Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis
.
Neuropathology and Applied Neurobiology
vol.
49
,
(
1
)
Schmierer K, Redha I, Hammond V, Baker D, Barkhof F, Hooper R, Rashid W, Singh-Curry V et al.
(
2022
)
.
152 AttackMS natalizumab for the treatment of people with inflammatory demyeli- nation suggestive of multiple sclerosis
.
Journal of Neurology Neurosurgery & Psychiatry
.
vol.
93
,
Schmierer K, Baker D, Nawaz T, Allen-Philbey K, Barkhof F, Chataway J, Hooper R, Mihaylova B et al.
(
2022
)
.
153 ChariotMS – cladribine to halt deterioration in people with advanced multiple sclerosis (pwAMS)
.
Journal of Neurology Neurosurgery & Psychiatry
.
vol.
93
,
Alford RF, Leaver-Fay A, Jeliazkov JR, O'Meara MJ, Dimaio FP, Park H, Shapovalov MV, Renfrew PD et al.
(
2022
)
.
Erratum: The Rosetta All-Atom Energy Function for Macromolecular Modeling and Design (J. Chem. Theory Comput. (2017) 13: 6 (3031-3048) DOI: 10.1021/acs.jctc.7b00125)
.
Journal of Chemical Theory and Computation
vol.
18
,
(
7
)
K A-P, A S, T B, AC J, A M, S G, R D, G G et al.
(
2022
)
.
Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis
.
Multiple Sclerosis and Related Disorders
vol.
65
,
Kouli O, Murray V, Bhatia S, Cambridge WA, Kawka M, Shafi S, Knight SR, Kamarajah SK et al.
(
2022
)
.
Evaluation of prognostic risk models for postoperative pulmonary complications in adult patients undergoing major abdominal surgery: a systematic review and international external validation cohort study
.
The Lancet Digital Health
vol.
4
,
(
7
)
e520
-
e531
.
Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N et al.
(
2022
)
.
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis
.
Multiple Sclerosis and Related Disorders
vol.
64
,
Baker D, MacDougall A, Kang AS, Schmierer K, Giovannoni G, Dobson R
(
2022
)
.
Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?
.
Clin Exp Immunol
vol.
207
,
(
3
)
263
-
271
.
Nutma E, Fancy N, Weinert M, Marzin MC, Tsartsalis S, Muirhead RCJ, Falk I, de Bruin J et al.
(
2022
)
.
Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases
.
Allen-Philbey K, Marta M, Gnanapavan S, Baker D, Schmierer K
(
2022
)
.
Disease activity after cladribine immune reconstitution therapy: To repeat or to retreat? (P9-4.002)
.
Neurology
vol.
98
,
(
18_supplement
)
Guo L, Luong V, Gregson A, Baker D, Selwood D, Cordeiro MF
(
2022
)
.
VSN16S, an agonist of the cannabinoid receptor, reduces IOP profiles and exhibits neuroprotective properties in a rat model of glaucoma
.
Acta Ophthalmologica
vol.
100
,
(
S267
)
Ichimura Y, Baker D
(
2022
)
.
Acute Inhalational Injury
.
Encyclopedia of Respiratory Medicine
,
Elsevier
Allen-Philbey K, Andrews M, Redha I, Papachatzaki M, Marta M, Gnanapavan S, Mathews J, Turner B et al.
(
2022
)
.
CLADRIPLAS: Does cladribine Target CNS plasma cells and reduce neuro-axonal damage in people with MS?
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
28
,
769
-
770
.
Vickaryous N, Rios F, Schalk L, Asardag AN, George K, Kang A, Baker D, Giovannoni G et al.
(
2022
)
.
COVID-19 humoral and T-cell mediated vaccination responses in people with multiple sclerosis
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
28
,
680
-
680
.
Upcott M, Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R et al.
(
2022
)
.
Humoral and T- cell response to multiple COVID-19 booster vaccinations in people with MS
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
28
,
365
-
366
.
Sgrò A, Blanco-Colino R, Ahmed WUR, Brindl N, Gujjuri RR, Lapolla P, Mills EC, Pérez-Ajates S et al.
(
2022
)
.
Intraperitoneal drain placement and outcomes after elective colorectal surgery: International matched, prospective, cohort study
.
British Journal of Surgery
vol.
109
,
(
3
)
520
-
529
.
Nasher F, Taylor AJ, Elmi A, Lehri B, Ijaz UZ, Baker D, Goram R, Lynham S et al.
(
2022
)
.
MdaB and NfrA, Two Novel Reductases Important in the Survival and Persistence of the Major Enteropathogen Campylobacter jejuni
.
Journal of Bacteriology
vol.
204
,
(
1
)
Baker D
(
2021
)
.
CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis
.
Multiple Sclerosis and Related Disorders
Mashe T, Takawira FT, de Oliveira Martins L, Gudza-Mugabe M, Chirenda J, Munyanyi M, Chaibva BV, Tarupiwa A et al.
(
2021
)
.
Genomic epidemiology and the role of international and regional travel in the SARS-CoV-2 epidemic in Zimbabwe: a retrospective study of routinely collected surveillance data
.
The Lancet Global Health
vol.
9
,
(
12
)
e1658
-
e1666
.
Klima JC, Doyle LA, Lee JD, Rappleye M, Gagnon LA, Lee MY, Barros EP, Vorobieva AA et al.
(
2021
)
.
Incorporation of sensing modalities into de novo designed fluorescence-activating proteins
.
Nature Communications
vol.
12
,
(
1
)
Wołoszyn P, Baumberg I, Baker D
(
2021
)
.
The high impulse, palm lift technique for chest compression: Prospective, experimental, pilot study
.
American Journal of Emergency Medicine
vol.
50
,
345
-
351
.
Allen-Philbey K, De Trane S, Mao Z, Álvarez-González C, Mathews J, MacDougall A, Stennett A, Zhou X et al.
(
2021
)
.
Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients
.
Therapeutic Advances in Neurological Disorders
vol.
14
,
Smets I, Holden D, Bianchi L, Ammoscato F, Allen-Philbey K, Baker D, Turner B, Marta M et al.
(
2021
)
.
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study
.
Multiple Sclerosis and Related Disorders
vol.
57
,
Baker D, MacDougall A, Kang AS, Schmierer K, Giovannoni G, Dobson R
(
2021
)
.
Seroconversion following COVID-19 vaccination: Can we optimize protective response in CD20-treated individuals?
.
Clinical & Experimental Immunology
vol.
207
,
(
3
)
Rupnik M, Baker D, Selwood DL
(
2021
)
.
Oligodendrocytes, BK channels and the preservation of myelin
.
F1000Research
vol.
10
,
Wilkinson E, Giovanetti M, Tegally H, San JE, Lessells R, Cuadros D, Martin DP, Rasmussen DA et al.
(
2021
)
.
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
.
Science
vol.
374
,
(
6566
)
423
-
431
.
Dobson R, Baker D, Kang A, Schmierer K, Giovannoni G
(
2021
)
.
COVID-19 vaccine response in people with multiple sclerosis
.
Annals of Neurology
Marta M, Baker D, Creeke P, Pryce G, Gnanapavan S, Giovannoni G
(
2021
)
.
Antigen-specific tolerization in human autoimmunity: Inhibition of interferon-beta1a anti-drug antibodies in multiple sclerosis: A case report
.
Multiple Sclerosis and Related Disorders
vol.
56
,
Romero-Romero S, Costas M, Silva Manzano DA, Kordes S, Rojas-Ortega E, Tapia C, Guerra Y, Shanmugaratnam S et al.
(
2021
)
.
The Stability Landscape of de novo TIM Barrels Explored by a Modular Design Approach
.
Journal of Molecular Biology
vol.
433
,
(
18
)
Rupnik M, Baker D, Selwood DL
(
2021
)
.
Oligodendrocytes, BK channels and remyelination
.
F1000Research
vol.
10
,
Baker D, Asardag AN, Quinn OA, Efimov A, Kang AS
(
2021
)
.
Anti-drug antibodies to antibody-based therapeutics in multiple sclerosis
.
Hum Antibodies
Giovannoni G, Hawkes CH, Lechner-Scott J, Levy M, Yeh EA, Baker D
(
2021
)
.
COVID-19 vaccines and multiple sclerosis disease-modifying therapies
.
Multiple Sclerosis and Related Disorders
vol.
53
,
Hall MD, Anderson JM, Anderson A, Baker D, Bradner J, Brimacombe KR, Campbell EA, Corbett KS et al.
(
2021
)
.
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
.
Journal of Infectious Diseases
vol.
224
,
S1
-
S21
.
Case JB, Chen RE, Cao L, Ying B, Winkler ES, Johnson M, Goreshnik I, Pham MN et al.
(
2021
)
.
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease
.
Cell Host and Microbe
vol.
29
,
(
7
)
1151
-
1161.e5
.
Patel V, Efimov A, Baker D, Kang AS
(
2021
)
.
Immunogenicity of biologics used in the treatment of moderate to severe psoriasis
.
Human Antibodies
vol.
29
,
(
3
)
171
-
178
.
Hurley MJ, Deacon RMJ, Chan AWE, Baker D, Selwood DL, Cogram P
(
2021
)
.
Reversal of behavioural phenotype by the cannabinoid-like compound VSN16R in fragile X syndrome mice
.
Brain
vol.
145
,
(
1
)
76
-
82
.
Bqain M, Efimov A, Baker D, Kang AS
(
2021
)
.
Immunogenicity of biologics used in the treatment of inflammatory bowel disease: A review
.
Human Antibodies
Baker D, Hadjicharalambous C, Gnanapavan S, Giovannoni G
(
2021
)
.
Can rheumatologists stop causing demyelinating disease?
.
Multiple Sclerosis and Related Disorders
vol.
53
,
Zhang S, Chen J, Liu J, Pyles H, Baker D, Chen CL, De Yoreo JJ
(
2021
)
.
Engineering Biomolecular Self-Assembly at Solid–Liquid Interfaces
.
Advanced Materials
vol.
33
,
(
23
)
Dobson R, ALLEN-PHILBEY K, Giovannoni G, Baker D, Schmierer K
(
2021
)
.
Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis
.
Multiple Sclerosis and Related Disorders
Allen-Philbey K, De Trane S, Stennett A, Yildiz O, Adams A, Turner B, Marta M, Gnanapavan S et al.
(
2021
)
.
Cladribine personalised dosing for active multiple sclerosis: BartsMS cohort follow-up (2528)
.
Neurology
vol.
96
,
(
15_supplement
)
Schmierer K, Sørensen PS, Baker D
(
2021
)
.
Highly effective disease-modifying treatment as initial MS therapy
.
Current Opinion in Neurology
vol.
34
,
(
3
)
286
-
294
.
Smets I, Reyes S, Baker D, Giovannoni G
(
2021
)
.
Blunted vaccines responses after ocrelizumab highlight need for immunizations prior to treatment
.
Multiple Sclerosis and Related Disorders
vol.
50
,
Allen-Philbey K, De Trane S, Stennett A, Yildiz O, Adams A, Turner B, Marta M, Gnanapavan S et al.
(
2021
)
.
Cladribine Personalised Dosing to Treat Active Multiple Sclerosis - Follow-up in 250 patients
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
27
,
90
-
91
.
Allen-Philbey K, De Trane S, Stennett A, Yildiz O, Adams A, Turner B, Marta M, Gnanapavan S et al.
(
2021
)
.
Cladribine personalised dosing for active multiple sclerosis: BartsMS cohort follow-up
.
NEUROLOGY
.
vol.
96
,
Smets I, Holden D, Bianchi L, Ammoscato F, Allen-Philbey K, Baker D, Turner B, Marta M et al.
(
2021
)
.
Factors contributing to CSF NfL reduction over time in people with multiple sclerosis starting treatment: an observational study
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
27
,
514
-
515
.
Vickaryous N, Asardag AN, Chance R, Jones M, Bestwick J, Shah SN, George K, Schmierer K et al.
(
2021
)
.
Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy
.
MULTIPLE SCLEROSIS JOURNAL
vol.
27
,
(
2_SUPPL
)
775
-
776
.
Allen-Philbey K, De Trane S, Stennett A, Yildiz O, Adams A, Turner B, Marta M, Gnanapavan S et al.
(
2021
)
.
Up to 6 years follow-up of people with MS (n=250) receiving cladribine
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
27
,
546
-
547
.
Guo L, Luong V, Gregson A, Baker D, Selwood D, Cordeiro MF
(
2021
)
.
VSN16S, an agonist of the cannabinoid receptor, reduces IOP profiles and exhibits neuroprotective properties in a rat model of glaucoma
.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
.
vol.
62
,
Isaacs-Ten A, Echeandia M, Moreno-Gonzalez M, Brion A, Goldson A, Philo M, Patterson AM, Parker A et al.
(
2020
)
.
Intestinal Microbiome-Macrophage Crosstalk Contributes to Cholestatic Liver Disease by Promoting Intestinal Permeability in Mice
.
Hepatology
vol.
72
,
(
6
)
2090
-
2108
.
Martin JT, Cottrell CA, Antanasijevic A, Carnathan DG, Cossette BJ, Enemuo CA, Gebru EH, Choe Y et al.
(
2020
)
.
Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations
.
npj Vaccines
vol.
5
,
(
1
)
Thomson A, Dobson R, Baker D, Giovannoni G
(
2020
)
.
Digesting science: Developing educational activities about multiple sclerosis, prevention and treatment to increase the confidence of affected families
.
Multiple Sclerosis and Related Disorders
vol.
47
,
Cunniffe N, Vuong KA, Ainslie D, Baker D, Beveridge J, Bickley S, Camilleri P, Craner M et al.
(
2020
)
.
Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis
.
Journal of Neurology, Neurosurgery and Psychiatry
Miao Y, Ha A, de Lau W, Yuki K, Santos AJM, You C, Geurts MH, Puschhof J et al.
(
2020
)
.
Next-Generation Surrogate Wnts Support Organoid Growth and Deconvolute Frizzled Pleiotropy In Vivo
.
Cell Stem Cell
vol.
27
,
(
5
)
840
-
851.e6
.
Cao L, Goreshnik I, Coventry B, Case JB, Miller L, Kozodoy L, Chen RE, Carter L et al.
(
2020
)
.
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
.
Science
vol.
370
,
(
6515
)
Wang LT, Pereira LS, Flores-Garcia Y, O'Connor J, Flynn BJ, Schön A, Hurlburt NK, Dillon M et al.
(
2020
)
.
A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver
.
Immunity
vol.
53
,
(
4
)
733
-
744.e8
.
Amor S, Fernández Blanco L, Baker D
(
2020
)
.
Innate immunity during SARS‐CoV‐2: evasion strategies and activation trigger hypoxia and vascular damage
.
Clinical & Experimental Immunology
vol.
202
,
(
2
)
193
-
209
.
Mateo-Casas M, Reyes S, De Trane S, Edwards F, Espasandin M, Anjorin G, Baker D, Schmierer K et al.
(
2020
)
.
Severe lymphopenia after subcutaneous cladribine in a patient with multiple sclerosis: To vaccinate or not?
.
eNeurologicalSci
vol.
21
,
Lajoie MJ, Boyken SE, Salter AI, Bruffey J, Rajan A, Langan RA, Olshefsky A, Muhunthan V et al.
(
2020
)
.
Designed protein logic to target cells with precise combinations of surface antigens
.
Science
vol.
369
,
(
6511
)
Kirkpatrick RL, Lewis K, Langan RA, Lajoie MJ, Boyken SE, Eakman M, Baker D, Zalatan JG
(
2020
)
.
Conditional Recruitment to a DNA-Bound CRISPR-Cas Complex Using a Colocalization-Dependent Protein Switch
.
ACS Synthetic Biology
vol.
9
,
(
9
)
2316
-
2323
.
Basanta B, Bick MJ, Bera AK, Norn C, Chow CM, Carter LP, Goreshnik I, Dimaio F et al.
(
2020
)
.
An enumerative algorithm for de novo design of proteins with diverse pocket structures
.
Proceedings of the National Academy of Sciences of the United States of America
vol.
117
,
(
36
)
22135
-
22145
.
Xu C, Lu P, Gamal El-Din TM, Pei XY, Johnson MC, Uyeda A, Bick MJ, Xu Q et al.
(
2020
)
.
Computational design of transmembrane pores
.
Nature
vol.
585
,
(
7823
)
129
-
134
.
Rasheed F, Saeed M, Alikhan NF, Baker D, Khurshid M, Ainsworth EV, Turner AK, Imran AA et al.
(
2020
)
.
Emergence of resistance to fluoroquinolones and third-generation cephalosporins in salmonella typhi in lahore, pakistan
.
Microorganisms
vol.
8
,
(
9
)
1
-
10
.
Jacobs B, Taylor T, Awad A, Baker D, Giovannoni G, Noyce A, Dobson R
(
2020
)
.
Summary-data-based mendelian randomisation prioritises potential druggable targets for Multiple Sclerosis
.
Brain Communications
Baker D, Roberts CAK, Pryce G, Kang AS, Marta M, Reyes S, Schmierer K, Giovannoni G et al.
(
2020
)
.
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases
.
Clinical and Experimental Immunology
vol.
202
,
(
2
)
149
-
161
.
Antanasijevic A, Ueda G, Brouwer PJM, Copps J, Huang D, Allen JD, Cottrell CA, Yasmeen A et al.
(
2020
)
.
Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens
.
PLoS Pathogens
vol.
16
,
(
8
)
Ueda G, Antanasijevic A, Fallas JA, Sheffler W, Copps J, Ellis D, Hutchinson GB, Moyer A et al.
(
2020
)
.
Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens
.
eLife
vol.
9
,
1
-
30
.
Petrova N, Nutma E, Carassiti D, Newman JR, Amor S, Altmann DR, Baker D, Schmierer K
(
2020
)
.
Synaptic Loss in Multiple Sclerosis Spinal Cord
.
Annals of Neurology
vol.
88
,
(
3
)
619
-
625
.
Leman JK, Weitzner BD, Lewis SM, Adolf-Bryfogle J, Alam N, Alford RF, Aprahamian M, Baker D et al.
(
2020
)
.
Macromolecular modeling and design in Rosetta: recent methods and frameworks
.
Nature Methods
vol.
17
,
(
7
)
665
-
680
.
Baker D
(
2020
)
.
Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis
.
Acta Neuropathologica
Saxena G, Moore JM, Jones M, Pryce G, Ali L, Leisegang GR, Vijay V, Loveless S et al.
(
2020
)
.
Detecting and predicting neutralization of alemtuzumab responses in MS
.
Neurology Neuroimmunology & Neuroinflammation
vol.
7
,
(
4
)
Baker D, Pryce G, James LK, Marta M, Schmierer K
(
2020
)
.
The ocrelizumab phase II extension trial suggests the potential to improve the risk:benefit balance in multiple sclerosis
.
Multiple Sclerosis and Related Disorders
Article
102279
,
102279
-
102279
.
Amor S, Baker D, Khoury SJ, Schmierer K, Giovanonni G
(
2020
)
.
SARS‐CoV‐2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad
.
Annals of Neurology
vol.
87
,
(
6
)
794
-
797
.
Baker D, Amor S, Kang AS, Schmierer K, Giovannoni G
(
2020
)
.
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
.
Multiple Sclerosis and Related Disorders
vol.
43
,
Leman JK, Weitzner BD, Renfrew PD, Lewis SM, Moretti R, Watkins AM, Mulligan VK, Lyskov S et al.
(
2020
)
.
Better together: Elements of successful scientific software development in a distributed collaborative community
.
PLoS Computational Biology
vol.
16
,
(
5
)
Mateo-Casas M, Reyes S, O'Toole EA, De Trane S, Yildiz O, Allen-Philbey K, Mathews J, Baker D et al.
(
2020
)
.
Severe skin reactions associated with cladribine in people with multiple sclerosis
.
Multiple Sclerosis and Related Disorders
.
vol.
43
,
Brunette TJ, Bick MJ, Hansen JM, Chow CM, Kollman JM, Baker D
(
2020
)
.
Modular repeat protein sculpting using rigid helical junctions
.
Proceedings of the National Academy of Sciences of the United States of America
vol.
117
,
(
16
)
8870
-
8875
.
Munger K, Kang A, Baker D, Goodman A, Samkoff L
(
2020
)
.
Alemtuzumab Depletion Failure and Neutralizing Anti-Drug Antibodies: a Case Report and Call for Monitoring (1347)
.
Neurology
vol.
94
,
(
15_supplement
)
Schmierer K, Baker D
(
2020
)
.
B cells and multiple sclerosis spinal cord pathology
.
Brain Pathology
vol.
30
,
(
4
)
730
-
731
.
Cannon KA, Park RU, Boyken SE, Nattermann U, Yi S, Baker D, King NP, Yeates TO
(
2020
)
.
Design and structure of two new protein cages illustrate successes and ongoing challenges in protein engineering
.
Protein Science
vol.
29
,
(
4
)
919
-
929
.
Wei KY, Moschidi D, Bick MJ, Nerli S, McShan AC, Carter LP, Huang PS, Fletcher DA et al.
(
2020
)
.
Computational design of closely related proteins that adopt two well-defined but structurally divergent folds
.
Proceedings of the National Academy of Sciences of the United States of America
vol.
117
,
(
13
)
7208
-
7215
.
Bertrand JA, Schicht M, Stamer WD, Baker D, Sherwood JM, Lütjen-Drecoll E, Selwood DL, Overby DR
(
2020
)
.
The beta(4)-Subunit of the Large-Conductance Potassium Ion Channel K(Ca)1.1 Regulates Outflow Facility in Mice
.
Investigative Ophthalmology and Visual Science
vol.
61
,
(
3
)
Ng AH, Nguyen TH, Gómez-Schiavon M, Dods G, Langan RA, Boyken SE, Samson JA, Waldburger LM et al.
(
2020
)
.
Publisher Correction: Modular and tunable biological feedback control using a de novo protein switch (Nature, (2019), 572, 7768, (265-269), 10.1038/s41586-019-1425-7)
.
Nature
vol.
579
,
(
7798
)
VanAernum ZL, Busch F, Jones BJ, Jia M, Chen Z, Boyken SE, Sahasrabuddhe A, Baker D et al.
(
2020
)
.
Rapid online buffer exchange for screening of proteins, protein complexes and cell lysates by native mass spectrometry
.
Nature Protocols
vol.
15
,
(
3
)
1132
-
1157
.
Baker DJ, Zall L
(
2020
)
.
The medea program: Opening a window into new earth science data
.
Oceanography
vol.
33
,
(
1
)
20
-
31
.
Ali L, SAXENA G, Jones M, Leisegang G, Gammon L, Gnanapavan S, Giovannoni G, Schmierer K et al.
(
2020
)
.
A cell-based assay for the detection of neutralizing antibodies against alemtuzumab
.
BioTechniques: the journal of laboratory technology for bioresearch
Baker D, Ali L, SAXENA G, Pryce G, Jones M, Schmierer K, Giovannoni G, Gnanapavan S et al.
(
2020
)
.
The irony of humanization: Alemtuzumab the first, but one of the most immunogenic, humanized monoclonal antibodies
.
Frontiers in Immunology
vol.
11
,
(
124
)
Saxena GK, Theocharopoulos I, Aziz NT, Jones M, Gnanapavan S, Giovannoni G, Schmierer K, Garnett JA et al.
(
2020
)
.
GloBody Technology: Detecting Anti-Drug Antibody against VH/VL domains
.
Scientific Reports
vol.
10
,
(
1
)
Article
1860
,
Hellner B, Alamdari S, Pyles H, Zhang S, Prakash A, Sprenger KG, De Yoreo JJ, Baker D et al.
(
2020
)
.
Sequence-Structure-Binding Relationships Reveal Adhesion Behavior of the Car9 Solid-Binding Peptide: An Integrated Experimental and Simulation Study
.
Journal of the American Chemical Society
vol.
142
,
(
5
)
2355
-
2363
.
Yang J, Anishchenko I, Park H, Peng Z, Ovchinnikov S, Baker D
(
2020
)
.
Improved protein structure prediction using predicted interresidue orientations
.
Proceedings of the National Academy of Sciences of the United States of America
vol.
117
,
(
3
)
1496
-
1503
.
Baker D, Pryce G, James LK, Marta M, Schmierer K
(
2020
)
.
The ocrelizumab phase II extension trial suggests the potential to improve the risk:benefit balance in multiple sclerosis
.
Multiple Sclerosis and Related Disorders2020.01.09.20016774
-
2020.01.09.20016774
.
Munger K, Kang A, Baker D, Goodman A, Samkoff L
(
2020
)
.
Alemtuzumab depletion failure and neutralizing anti-drug antibodies: a case report and call for monitoring
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
26
,
258
-
258
.
Baker DJ
(
2020
)
.
Artificial Ventilation, A Basic Clinical Guide
.
Springer Nature
Allen-Philbey K, De Trane S, Stennett A, Yildiz O, Adams A, Turner B, Marta M, Gnanapavan S et al.
(
2020
)
.
Cladribine personalised dosing to treat multiple sclerosis: observations in 208 patients
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
26
,
522
-
523
.
Lieberman D, Mangat H, Allen-Philbey K, Baker D, Barkhof F, Chandran S, Chapman C, Chataway J et al.
(
2020
)
.
Cladribine to halt deterioration in people with advanced multiple sclerosis (CHARIOTMS)
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
26
,
212
-
213
.
Farrell DP, Anishchenko I, Shakeel S, Lauko A, Passmore LA, Baker D, DiMaio F
(
2020
)
.
Deep learning enables the atomic structure determination of the Fanconi Anemia core complex from cryoEM
.
IUCrJ
vol.
7
,
881
-
892
.
Foster-Nyarko E, Alikhan NF, Ravi A, Thilliez G, Thomson NM, Baker D, Kay G, Cramer JD et al.
(
2020
)
.
Genomic diversity of Escherichia coli isolates from non-human primates in the Gambia
.
Microbial Genomics
vol.
6
,
(
9
)
1
-
15
.
Yager P, Abe K, Anderson CE, Baker D, Belousov Y, Bishop J, Buser JR, Byrnes SA et al.
(
2020
)
.
Low-cost disposable point-of-care devices based on porous materials for rapid detection of pathogens
.
21st International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2017
.
97
-
100
.
Dou J, Goreshnik I, Bryan C, Baker D, Strauch EM
(
2020
)
.
Parallelized identification of on- A nd off-target protein interactions
.
Molecular Systems Design and Engineering
vol.
5
,
(
1
)
349
-
357
.
Wu Q, Peng Z, Anishchenko I, Cong Q, Baker D, Yang J
(
2020
)
.
Protein contact prediction using metagenome sequence data and residual neural networks
.
Bioinformatics
vol.
36
,
(
1
)
41
-
48
.
Yasir M, Keith Turner A, Bastkowski S, Baker D, Page AJ, Telatin A, Phan MD, Monahan L et al.
(
2020
)
.
TRADIS-XPress: A high-resolution whole-genome assay identifies novel mechanisms of triclosan action and resistance
.
Genome Research
vol.
30
,
(
2
)
239
-
249
.
Yin Y, Ochi N, Craven TW, Baker D, Takigawa N, Suga H
(
2019
)
.
De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor
.
Journal of the American Chemical Society
vol.
141
,
(
49
)
19193
-
19197
.
Weitzner BD, Kipnis Y, Daniel AG, Hilvert D, Baker D
(
2019
)
.
A computational method for design of connected catalytic networks in proteins
.
Protein Science
vol.
28
,
(
12
)
2036
-
2041
.
Valliere MA, Korman TP, Woodall NB, Khitrov GA, Taylor RE, Baker D, Bowie JU
(
2019
)
.
Author Correction: A cell-free platform for the prenylation of natural products and application to cannabinoid production (Nature Communications, (2019), 10, 1, (565), 10.1038/s41467-019-08448-y)
.
Nature Communications
vol.
10
,
(
1
)
Park J, Selvaraj B, McShan AC, Boyken SE, Wei KY, Oberdorfer G, Degrado W, Sgourakis NG et al.
(
2019
)
.
De novo design of a homo-trimeric amantadine-binding protein
.
eLife
vol.
8
,
Brouwer PJM, Antanasijevic A, Berndsen Z, Yasmeen A, Fiala B, Bijl TPL, Bontjer I, Bale JB et al.
(
2019
)
.
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
.
Nature Communications
vol.
10
,
(
1
)
Park H, Lee GR, Kim DE, Anishchenko I, Cong Q, Baker D
(
2019
)
.
High-accuracy refinement using Rosetta in CASP13
.
Proteins: Structure, Function and Bioinformatics
vol.
87
,
(
12
)
1276
-
1282
.
Porter KA, Padhorny D, Desta I, Ignatov M, Beglov D, Kotelnikov S, Sun Z, Alekseenko A et al.
(
2019
)
.
Template-based modeling by ClusPro in CASP13 and the potential for using co-evolutionary information in docking
.
Proteins: Structure, Function and Bioinformatics
vol.
87
,
(
12
)
1241
-
1248
.
Baker D, Pryce G, James LK, Schmierer K, Giovannoni G
(
2019
)
.
Failed B cell survival factor trials support the importance of memory B cells in multiple sclerosis
.
European Journal of Neurology
vol.
27
,
(
2
)
221
-
228
.
Barros EP, Schiffer JM, Vorobieva A, Dou J, Baker D, Amaro RE
(
2019
)
.
Improving the Efficiency of Ligand-Binding Protein Design with Molecular Dynamics Simulations
.
Journal of Chemical Theory and Computation
vol.
15
,
(
10
)
5703
-
5715
.
Farrell R, Baker D
(
2019
)
.
An expert opinion: Optimisation of pharmacological management of multiple sclerosis related spasticity
.
Advances in Clinical Neuroscience and Rehabilitation
vol.
18
,
(
5
)
17
-
19
.
Foight GW, Wang Z, Wei CT, Greisen P, Warner KM, Cunningham-Bryant D, Park K, Brunette TJ et al.
(
2019
)
.
Multi-input chemical control of protein dimerization for programming graded cellular responses
.
Nature Biotechnology
vol.
37
,
(
10
)
1209
-
1216
.
Wołoszyn P, Baumberg I, Baker D
(
2019
)
.
The Reliability of Noninvasive Blood Pressure Measurement Through Layers of Autumn/Winter Clothing: A Prospective Study
.
Wilderness and Environmental Medicine
vol.
30
,
(
3
)
227
-
235
.
Langan RA, Boyken SE, Ng AH, Samson JA, Dods G, Westbrook AM, Nguyen TH, Lajoie MJ et al.
(
2019
)
.
De novo design of bioactive protein switches
.
Nature
vol.
572
,
(
7768
)
205
-
210
.
Ng AH, Nguyen TH, Gómez-Schiavon M, Dods G, Langan RA, Boyken SE, Samson JA, Waldburger LM et al.
(
2019
)
.
Modular and tunable biological feedback control using a de novo protein switch
.
Nature
vol.
572
,
(
7768
)
265
-
269
.
Baker D, Amor S
(
2019
)
.
Autoimmune encephalomyelitis in NOD mice is not initially a progressive multiple sclerosis model
.
Annals of Clinical and Translational Neurology
Pyles H, Zhang S, De Yoreo JJ, Baker D
(
2019
)
.
Controlling protein assembly on inorganic crystals through designed protein interfaces
.
Nature
vol.
571
,
(
7764
)
251
-
256
.
Batcheller L, Baker D
(
2019
)
.
Cost of disease modifying therapies for multiple sclerosis: Is front-loading the answer?
.
Journal of the Neurological Sciences
vol.
404
,
19
-
28
.
Tabatabaee S, Baker D, Selwood DL, Whalley BJ, Stephens GJ
(
2019
)
.
The Cannabinoid-Like Compound, VSN16R, Acts on Large Conductance, Ca2+-Activated K+ Channels to Modulate Hippocampal CA1 Pyramidal Neuron Firing
.
Pharmaceuticals
vol.
12
,
(
3
)
Baker D
(
2019
)
.
Computationally designed protein activation
.
National Science Review
vol.
6
,
(
4
)
609
-
610
.
Baker D, Jacobs BM, Gnanapavan S, Schmierer K, Giovannoni G
(
2019
)
.
Plasma cell and B cell-targeted treatments for use in advanced multiple sclerosis
.
Multiple Sclerosis and Related Disorders
vol.
35
,
19
-
25
.
Koepnick B, Flatten J, Husain T, Ford A, Silva DA, Bick MJ, Bauer A, Liu G et al.
(
2019
)
.
De novo protein design by citizen scientists
.
Nature
vol.
570
,
(
7761
)
390
-
394
.
Pryce G, Baker D
(
2019
)
.
CHAPTER 11 Cannabinoids as a Therapeutic Approach in Multiple Sclerosis
.
Emerging Drugs and Targets for Multiple Sclerosis
,
Royal Society of Chemistry (RSC)
Bulutoglu B, Macazo FC, Bale J, King N, Baker D, Minteer SD, Banta S
(
2019
)
.
Multimerization of an Alcohol Dehydrogenase by Fusion to a Designed Self-Assembling Protein Results in Enhanced Bioelectrocatalytic Operational Stability
.
ACS Applied Materials and Interfaces
vol.
11
,
(
22
)
20022
-
20028
.
Chen Z, Johnson MC, Chen J, Bick MJ, Boyken SE, Lin B, De Yoreo JJ, Kollman JM et al.
(
2019
)
.
Self-Assembling 2D Arrays with de Novo Protein Building Blocks
.
Journal of the American Chemical Society
vol.
141
,
(
22
)
8891
-
8895
.
Dang LT, Miao Y, Ha A, Yuki K, Park K, Janda CY, Jude KM, Mohan K et al.
(
2019
)
.
Receptor subtype discrimination using extensive shape complementary designed interfaces
.
Nature Structural and Molecular Biology
vol.
26
,
(
6
)
407
-
414
.
Mohan K, Ueda G, Kim AR, Jude KM, Fallas JA, Guo Y, Hafer M, Miao Y et al.
(
2019
)
.
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
.
Science
vol.
364
,
(
6442
)
Cao L, Yu B, Kong D, Cong Q, Yu T, Chen Z, Hu Z, Chang H et al.
(
2019
)
.
Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus
.
PLoS Pathogens
vol.
15
,
(
5
)
De Trane S, Mao Z, Alvarez-Gonzalez C, Allen-Philbey K, Yildiz O, Campion T, Adams A, Turner B et al.
(
2019
)
.
Cladribine to treat Relapsing and Progressive Multiple Sclerosis - experience in >200 patients (S26.008)
.
Neurology
vol.
92
,
(
15_supplement
)
Baker D, Pryce G, Herrod SS, Schmierer K
(
2019
)
.
Potential mechanisms of action related to the efficacy and safety of cladribine
.
Multiple Sclerosis and Related Disorders
vol.
30
,
176
-
186
.
Khatib F, Desfosses A, Players F, Koepnick B, Flatten J, Popović Z, Baker D, Cooper S et al.
(
2019
)
.
Building de novo cryo-electron microscopy structures collaboratively with citizen scientists
.
PLoS Biology
vol.
17
,
(
11
)
Pryce G, Baker D
(
2019
)
.
CHAPTER 11: Cannabinoids as a Therapeutic Approach in Multiple Sclerosis
.
RSC Drug Discovery Series
,
vol.
2019-January
,
Boyken SE, Benhaim MA, Busch F, Jia M, Bick MJ, Choi H, Klima JC, Chen Z et al.
(
2019
)
.
De novo design of tunable, pH-driven conformational changes
.
Science
vol.
364
,
(
6442
)
658
-
664
.
Snyder AG, Hubbard NW, Messmer MN, Kofman SB, Hagan CE, Orozco SL, Chiang K, Daniels BP et al.
(
2019
)
.
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity
.
Science Immunology
vol.
4
,
(
36
)
Cong Q, Anishchenko I, Ovchinnikov S, Baker D
(
2019
)
.
Protein interaction networks revealed by proteome coevolution
.
Science
vol.
365
,
(
6449
)
185
-
189
.
Day AL, Greisen P, Doyle L, Schena A, Stella N, Johnsson K, Baker D, Stoddard B
(
2018
)
.
Unintended specificity of an engineered ligand-binding protein facilitated by unpredicted plasticity of the protein fold
.
Protein Engineering Design and Selection
vol.
31
,
(
10
)
375
-
387
.
Mao Z, Álvarez-González C, Allen-Philbey K, De Trane S, Yildiz O, Campion T, Adams A, Turner BP et al.
(
2018
)
.
Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies
.
Multiple Sclerosis and Related Disorders
vol.
27
,
247
-
253
.
Dubuisson N, Marta M, Gnanapavan S, Turner B, Baker D, Thomson A, Schmierer K, Giovannoni G
(
2018
)
.
Inclusion criteria used in trials of people with progressive multiple sclerosis
.
Mult Scler1352458518803769
-
1352458518803769
.
Maguire JB, Boyken SE, Baker D, Kuhlman B
(
2018
)
.
Correction to Rapid Sampling of Hydrogen Bond Networks for Computational Protein Design
.
Journal of Chemical Theory and Computation
vol.
14
,
(
10
)
5434
-
5434
.
BAKER D, GIOVANNONI G, PRYCE G, AMOR S, SCHMIERER K
(
2018
)
.
Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis
.
Brain
BO XUENONG, GUSHCHINA S, PRYCE G, YIP P, WU D, PALLIER P, GIOVANNONI G, BAKER D
(
2018
)
.
Increased expression of colony‐stimulating factor‐1 in mouse spinal cord with experimental autoimmune encephalomyelitis correlates with microglial activation and neuronal loss
.
Glia
vol.
66
,
(
10
)
2108
-
2125
.
BAKER D, Pryce, G
(
2018
)
.
Oligoclonal bands in multiple sclerosis; functional significance and therapeutic implications. Does the specificity matter?
.
multiple sclerosis and related disorders
Bavinton BR, Pinto AN, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, Jin F, Fairley CK et al.
(
2018
)
.
Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
.
The Lancet HIV
vol.
5
,
(
8
)
e438
-
e447
.
Jacobs BM, Ammoscato F, Giovannoni G, Baker D, Schmierer K
(
2018
)
.
Cladribine: mechanisms and mysteries in multiple sclerosis
.
Journal of Neurology Neurosurgery & Psychiatry
vol.
89
,
(
12
)
Mao Z, Álvarez-Gonzalez C, De Trane S, Yildiz O, Albor C, Doctor G, Soon D, Pepper G et al.
(
2018
)
.
Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?
.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
vol.
4
,
(
2
)
2055217318783767
-
2055217318783767
.
Yildiz O, Mao Z, Adams A, Dubuisson N, Allen-Philbey K, Giovannoni G, Malaspina A, Baker D et al.
(
2018
)
.
Disease activity in progressive multiple sclerosis can be effectively reduced by cladribine
.
Multiple Sclerosis and Related Disorders
vol.
24
,
20
-
27
.
Nicholson T, Church C, Baker DJ, Jones SW
(
2018
)
.
The role of adipokines in skeletal muscle inflammation and insulin sensitivity
.
Journal of Inflammation
vol.
15
,
(
1
)
Ceronie B, Dubuisson N, Ammoscato F, Baker D, Giovannoni G, Schmierer K
(
2018
)
.
Memory B Cells: Toward a Unified Therapeutic Target for Effective Immunotherapy in Multiple Sclerosis (P5.365)
.
Neurology
.
vol.
90
,
Ceronie B, Jacobs BM, Baker D, Dubuisson N, Mao Z, Ammoscato F, Lock H, Longhurst HJ et al.
(
2018
)
.
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
.
Journal of Neurology
vol.
265
,
(
5
)
1199
-
1209
.
Biggs EK, Liang L, Naylor J, Madalli S, Collier R, Coghlan MP, Baker DJ, Hornigold DC et al.
(
2018
)
.
Development and characterisation of a novel glucagon like peptide-1 receptor antibody
.
Diabetologia
vol.
61
,
(
3
)
711
-
721
.
Dubuisson N, Baker D, Kang AS, Pryce G, Marta M, Visser LH, Hofmann WE, Gnanapavan S et al.
(
2018
)
.
Alemtuzumab depletion failure can occur in multiple sclerosis
.
Immunology
vol.
154
,
(
2
)
253
-
260
.
Ruz-Maldonado I, Liu B, Atanes P, Pingitore A, Huang GC, Baker D, Persaud SJ
(
2018
)
.
CB1 antagonists SR141617A and AM251 stimulate insulin secretion from mouse and human islets
.
DIABETIC MEDICINE
.
vol.
35
,
47
-
47
.
De Trane S, Mao Z, Alvarez-Gonzalez C, Allen-Philbey K, Yildiz O, Campion T, Adams A, Turner BP et al.
(
2018
)
.
Cladribine personalised dosing in people with MS (n>200) - four years experience in clinical care
.
Yildiz O, Mao Z, Adams A, Dubuisson N, Allen-Philbey K, Giovannoni G, Malaspina A, Baker D et al.
(
2018
)
.
Elevated neurofilament light chain levels in progressive multiple sclerosis effectively reduced by cladribine treatment
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
24
,
949
-
949
.
Ruz-Maldonado I, Pingitore A, Liu B, Atanes P, Huang GC, Baker D, Alonso FJ, Bermúdez-Silva FJ et al.
(
2017
)
.
LH‐21 and abnormal cannabidiol improve β‐cell function in isolated human and mouse islets through GPR55‐dependent and ‐independent signalling
.
Diabetes Obes Metab
vol.
20
,
(
4
)
930
-
942
.
Agez M, Schultz P, Medina I, Baker DJ, Burnham MP, Cardarelli RA, Conway LC, Garnier K et al.
(
2017
)
.
Molecular architecture of potassium chloride co-transporter KCC2
.
Scientific Reports
vol.
7
,
(
1
)
Dubuisson N, Bauer A, Marta M, Gnanapavan S, Turner B, Baker D, Giovannoni G, Schmierer K et al.
(
2017
)
.
PO124 Validation of an environmentally-friendly and affordable cardboard 9-hole peg test
.
Journal of Neurology Neurosurgery & Psychiatry
.
vol.
88
,
Schmierer K, Marta M, Pryce G, Giovannoni G, Baker D
(
2017
)
.
PO150 Memory b cells are key for immunotherapy in multiple sclerosis
.
Journal of Neurology Neurosurgery & Psychiatry
.
vol.
88
,
a52
-
a52
.
Baker D, Giovannoni G, Schmierer K
(
2017
)
.
Marked neutropenia: significant but rare in people with multiple sclerosis after alemtuzumab treatment
.
Multiple Sclerosis and Related Disorders
BAKER D
(
2017
)
.
SPATIAL DISTRIBUTION OF THE CANNABINOID TYPE 1 AND CAPSAICIN RECEPTORS MAY CONTRIBUTE TO THE COMPLEXITY OF THEIR CROSSTALK
.
Scientific Reports
Pryce G, Baker D
(
2017
)
.
Antidote to cannabinoid intoxication: the CB1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB1 receptor agonist, CB‐13, in mice
.
British Journal of Pharmacology
vol.
174
,
(
21
)
3790
-
3794
.
Baker D, Herrod SS, Alvarez-Gonzalez C, Zalewski L, Albor C, Schmierer K
(
2017
)
.
Both cladribine and alemtuzumab may affect MS via B-cell depletion (vol 4, e360, 2017)
.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION
vol.
4
,
(
5
)
Puentes F, Star BJ, Boomkamp SD, Kipp M, Boon L, Bosca I, Raffel J, Gnanapavan S et al.
(
2017
)
.
Neurofilament light as an immune target for pathogenic antibodies
.
Immunology
vol.
152
,
(
4
)
580
-
588
.
Dubuisson N, Bauer A, Buckley M, Gilbert R, Paterson A, Marta M, Gnanapavan S, Turner B et al.
(
2017
)
.
Validation of an environmentally-friendly and affordable cardboard 9-hole peg test
.
Multiple Sclerosis and Related Disorders
vol.
17
,
172
-
176
.
Baker D, Herrod SS, Alvarez-Gonzalez C, Giovannoni G, Schmierer K
(
2017
)
.
Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab
.
JAMA Neurol
vol.
74
,
(
8
)
961
-
969
.
Afolabi D, Albor C, Zalewski L, Altmann DR, Baker D, Schmierer K
(
2017
)
.
Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis
.
Mult Scler1352458517726380
-
1352458517726380
.
BAKER D
(
2017
)
.
Big conductance calcium-activated potassium channel openers control spasticity without sedation
.
British Journal of Pharmcology
Dubuisson N, Baker D, Thomson A, Marta M, Gnanapavan S, Turner B, Giovannoni G, Schmierer K
(
2017
)
.
Disease modification in advanced MS: Focus on upper limb function
.
Multiple Sclerosis Journal
vol.
23
,
(
14
)
1956
-
1957
.
Baker D, Herrod SS, Alvarez-Gonzalez C, Zalewski L, Albor C, Schmierer K
(
2017
)
.
Both cladribine and alemtuzumab may effect MS via B-cell depletion
.
Neurology Neuroimmunology & Neuroinflammation
vol.
4
,
(
4
)
BAKER D, SCHMIERER K, Herrod S, Alvarez Gonzalez C, Zalewski L, Albor C
(
2017
)
.
Both cladribine and alemtuzumab may effect multiple sclerosis via B cell depletion
.
Neurology: Neuroimmunology and Neuroinflammation
vol.
4
,
(
4
)
Alvarez-Gonzalez C, Adams A, Mathews J, Turner BP, Giovannoni G, Baker D, Schmierer K
(
2017
)
.
Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis
.
Annals of Clinical and Translational Neurology
Petrova N, Carassiti D, Altmann DR, Baker D, Schmierer K
(
2017
)
.
Axonal loss in the multiple sclerosis spinal cord revisited
.
Brain Pathology
vol.
28
,
(
3
)
334
-
348
.
BAKER D, Giovannoni G, Sefia E, Pryce G, Meier U
(
2017
)
.
Depletion of CD20 B cells fails to inhibit relapsing mouse experimental autoimmune encephalomyelitis
.
Multiple Sclerosis and Related Disorders
Schmierer K, Herrod S, Alvarez-Gonzalez C, Baker D
(
2017
)
.
Cladribine versus Alemtuzumab: efficacy and autoimmunity in multiple sclerosis induction treatment (P6.383)
.
Neurology
.
vol.
88
,
Thomson A, Raciborska D, Baker D, Giovannoni G
(
2017
)
.
How to start a blog
.
Pract Neurol
vol.
17
,
(
3
)
224
-
228
.
Baumberg I, Baker D, Wołoszyn P, Andres J, Kopacki W, Krawczyk P, Gaszyński W
(
2017
)
.
The timing of chest compressions and artificial ventilation: A re-appraisal
.
The American Journal of Emergency Medicine
vol.
35
,
(
10
)
1569
-
1571
.
Lecommandeur E, Baker D, Cox TM, Nicholls AW, Griffin JL
(
2017
)
.
Alterations in endo-lysosomal function induce similar hepatic lipid profiles in rodent models of drug-induced phospholipidosis and Sandhoff disease
.
Journal of Lipid Research
vol.
58
,
(
7
)
1306
-
1314
.
Baker D, Marta M, Pryce G, Giovannoni G, Schmierer K
(
2017
)
.
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
.
EBioMedicine
vol.
16
,
41
-
50
.
Giovannoni G, Cutter G, Pia-Sormani M, Belachew S, Hyde R, Koendgen H, Knappertz V, Tomic D et al.
(
2017
)
.
Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses
.
Multiple Sclerosis and Related Disorders
vol.
12
,
70
-
78
.
Kutzleben S, Pryce G, Giovannoni G, Baker D
(
2017
)
.
Depletion of CD52‐positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune‐tolerance promoting CD8 T‐cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis
.
Immunology
vol.
150
,
(
4
)
444
-
455
.
Baker D, Kang AS, Gnanapavan S, Giovannoni G, Schmierer K
(
2017
)
.
A central role of B cells in MS control and causing autoimmunity after alemtuzumab
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
23
,
336
-
336
.
Alvarez-Gonzalez C, Allen-Philbey K, Mathews J, Turner BP, Baker D, Gnanapavan S, Marta M, Giovannoni G et al.
(
2016
)
.
TREATING MULTIPLE SCLEROSIS WITH CLADRIBINE
.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
.
Conference:
MSLondon (ACTRIMS/ECTRIMS) 2016
vol.
87
,
Williams T, Pryce G, Giovannoni G, Selwood D, Baker D
(
2016
)
.
VSN16R-A NOVEL TREATMENT FOR SPASTICITY IN EXPERIMENTAL MULTIPLE SCLEROSIS
.
vol.
87
,
is.
12
,
Abstract:
java.sql.Clob
org.hibernate.engine.jdbc.WrappedClob
java.io.Serializable
,
Baker D, Anandhakrishnan A, Tuite-Dalton KA, Lockart–Jones H, Middleton RM, Ford DV, Crowe C, Giovannoni G
(
2016
)
.
How to refer to people with disease in research outputs: The disconnection between academic practise and that preferred by people with multiple sclerosis
.
Multiple Sclerosis and Related Disorders
vol.
10
,
127
-
133
.
Liu B, Song S, Ruz-Maldonado I, Pingitore A, Huang GC, Baker D, Jones PM, Persaud SJ
(
2016
)
.
GPR55‐dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans
.
Diabetes Obesity and Metabolism
vol.
18
,
(
12
)
1263
-
1273
.
Horowitz S, Koepnick B, Martin R, Tymieniecki A, Winburn AA, Cooper S, Flatten J, Rogawski DS et al.
(
2016
)
.
Determining crystal structures through crowdsourcing and coursework
.
Nature Communications
vol.
7
,
(
1
)
Agahozo MC, Peferoen L, Baker D, Amor S
(
2016
)
.
CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis – Targeting T or B cells?
.
Multiple Sclerosis and Related Disorders
vol.
9
,
Article
C
,
110
-
117
.
Thomson A, Giovannoni G, Marta M, Gnanpavan S, Turner B, Baker D, Schmierer K
(
2016
)
.
Importance of upper limb function in advanced multiple sclerosis
.
MULTIPLE SCLEROSIS JOURNAL
.
Conference:
MSLondon (ACTRIMS/ECTRIMS) 2016
vol.
22
,
676
-
676
.
Rejdak K, Mitosek-Szewczyk K, Prus K, Trzciniecka O, Baker D, Schmierer K, Stelmasiak Z
(
2016
)
.
Induction therapy of relapsing secondary multiple sclerosis using generic cladribine
.
MULTIPLE SCLEROSIS JOURNAL
.
Conference:
MSLondon (ACTRIMS/ECTRIMS) 2016
vol.
22
,
593
-
594
.
Petrova N, Carassiti D, Scaravilli F, Baker D, Schmierer K
(
2016
)
.
Synaptic loss in the MS spinal cord: a key driver of disease progression?
.
MULTIPLE SCLEROSIS JOURNAL
.
Conference:
ECTRIMS 2016 Committees
(
UCL Institute of Neurology, London, UK
)
from:
14/09/2016
to:
17/09/2016
,
vol.
22
,
80
-
80
.
Alvarez-Gonzalez C, Allen-Philbey K, Mathews J, Espasandin M, Turner BP, Gnanapavan S, Marta M, Giovannoni G et al.
(
2016
)
.
Treating multiple sclerosis with generic cladribine
.
MULTIPLE SCLEROSIS JOURNAL
.
Conference:
MSLondon (ACTRIMS/ECTRIMS)
vol.
22
,
604
-
605
.
Burnham SC, Rowe CC, Baker D, Bush AI, Doecke JD, Faux NG, Laws SM, Martins RN et al.
(
2016
)
.
Predicting Alzheimer disease from a blood-based biomarker profile
.
Neurology
vol.
87
,
(
11
)
1093
-
1101
.
Peferoen LAN, Breur M, van de Berg S, Peferoen-Baert R, Boddeke EHWGM, van der Valk P, Pryce G, van Noort JM et al.
(
2016
)
.
Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice
.
Immunology
vol.
149
,
(
2
)
146
-
156
.
Baird AL, Hye A, Westwood S, Ashton NJ, Liu BY, Bazenet C, Kiddle SJ, Ward M et al.
(
2016
)
.
S4‐01‐01: Cross‐Sectional Studies of Plasma Proteomic Biomarkers Relating to Pet Amyloid and CSF Amyloid and Tau
.
Alzheimer's & Dementia
vol.
12
,
(
7S_Part_6
)
p321
-
p321
.
Sevastou I, Pryce G, Baker D, Selwood DL
(
2016
)
.
Characterisation of Transcriptional Changes in the Spinal Cord of the Progressive Experimental Autoimmune Encephalomyelitis Biozzi ABH Mouse Model by RNA Sequencing
.
PLOS ONE
vol.
11
,
(
6
)
e0157754
-
e0157754
.
Baker DJ, Bradley N, Dobney A, Murray V, Meara JR, O’Hagan J, McColl NP, Cox CL
(
2016
)
.
Human physiology, hazards and health risks
.
Clay’s Handbook of Environmental Health, 21st Edition
,
Warne J, Pryce G, Hill JM, Shi X, Lennerås F, Puentes F, Kip M, Hilditch L et al.
(
2015
)
.
Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis*
.
Journal of Biological Chemistry
vol.
291
,
(
9
)
4356
-
4373
.
Ummenthum K, Peferoen LAN, Finardi A, Baker D, Pryce G, Mantovani A, Bsibsi M, Bottazzi B et al.
(
2015
)
.
Pentraxin‐3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease
.
European Journal of Immunology
vol.
46
,
(
3
)
701
-
711
.
Baker DJ
(
2015
)
.
Chapter 16 Acute Lung Injury Following Inhalation of Irritant Products of Combustion
.
Toxicology, Survival and Health Hazards of Combustion Products
,
Royal Society of Chemistry (RSC)
Pakpoor J, Disanto G, Altmann DR, Pavitt S, Turner BP, Marta M, Juliusson G, Baker D et al.
(
2015
)
.
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine
.
Neurology Neuroimmunology & Neuroinflammation
vol.
2
,
(
6
)
Leung YY, Toledo JB, Nefedov A, Polikar R, Raghavan N, Xie SX, Farnum M, Schultz T et al.
(
2015
)
.
Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study
.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
vol.
1
,
(
3
)
339
-
348
.
Park H, DiMaio F, Baker D
(
2015
)
.
CASP11 refinement experiments with ROSETTA
.
Proteins Structure Function and Bioinformatics
vol.
84
,
(
S1
)
314
-
322
.
Spellman DS, Wildsmith KR, Honigberg LA, Tuefferd M, Baker D, Raghavan N, Nairn AC, Croteau P et al.
(
2015
)
.
Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF
.
Proteomics - Clinical Applications
vol.
9
,
(
7-8
)
715
-
731
.
D'Amato G, Holgate ST, Pawankar R, Ledford DK, Cecchi L, Al-Ahmad M, Al-Enezi F, Al-Muhsen S et al.
(
2015
)
.
Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization
.
World Allergy Organization Journal
vol.
8
,
(
1
)
Raghavan N, Ard MC, Baker D, Narayan VA, Edland S, Team TAR
(
2015
)
.
P3‐308: The adcs‐pacc composite endpoint: An assessment of sample size efficiencies in the aibl study of aging using optimally weighted components
.
Alzheimer's & Dementia
vol.
11
,
(
7S_Part_16
)
p755
-
p755
.
Budgeon CA, Murray K, Turlach BA, Baker D, Villemagne VL, Burnham S
(
2015
)
.
P4‐228: Techniques for assessing Alzheimer's disease progression
.
Alzheimer's & Dementia
vol.
11
,
(
7S_Part_19
)
p867
-
p868
.
Voyle N, Baker D, Burnham SC, Covin A, Zhang Z, Sangurdekar DP, Tan Hehir CA, Bazenet C et al.
(
2015
)
.
Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology
.
Journal of Alzheimer's Disease
vol.
46
,
(
4
)
947
-
961
.
Burnham SC, Raghavan N, Wilson W, Baker D, Ropacki MT, Novak G, Ames D, Ellis K et al.
(
2015
)
.
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study
.
Journal of Alzheimer's Disease
vol.
46
,
(
4
)
1079
-
1089
.
Ramaglia V, Jackson SJ, Hughes TR, Neal JW, Baker D, Morgan BP
(
2015
)
.
Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse
.
Clinical and Experimental Immunology
vol.
180
,
(
3
)
432
-
441
.
Waring MJ, Baker DJ, Bennett SNL, Dossetter AG, Fenwick M, Garcia R, Georgsson J, Groombridge SD et al.
(
2015
)
.
Discovery of a series of 2-(pyridinyl)pyrimidines as potent antagonists of GPR40
.
MedChemComm
vol.
6
,
(
6
)
1024
-
1029
.
Ramaglia V, Jackson SJ, Hughes TR, Neal JW, Baker D, Morgan BP
(
2015
)
.
Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse
.
Clinical & Experimental Immunology
vol.
180
,
(
3
)
432
-
441
.
Pryce G, Baker D
(
2015
)
.
Cannabinoids fail to show evidence of slowing down the progression of multiple sclerosis
.
BMJ Evidence-Based Medicine
vol.
20
,
(
4
)
Browne L, Lidster K, Al-Izki S, Clutterbuck L, Posada C, Chan AWE, Riddall D, Garthwaite J et al.
(
2015
)
.
Correction to Imidazol-1-ylethylindazole Voltage-Gated Sodium Channel Ligands Are Neuroprotective during Optic Neuritis in a Mouse Model of Multiple Sclerosis
.
Journal of Medicinal Chemistry
vol.
58
,
(
8
)
3637
-
3637
.
Pakpoor J, Disanto G, Altmann D, Pavitt S, Turner B, Marta M, Juliusson G, Baker D et al.
(
2015
)
.
Cancer Risk is Not Increased in People with Relapsing Multiple Sclerosis Taking Cladribine (P7.011)
.
Neurology
vol.
84
,
(
14_supplement
)
Ashton NJ, Kiddle SJ, Graf J, Ward M, Baird AL, Hye A, Westwood S, Wong KV et al.
(
2015
)
.
Blood protein predictors of brain amyloid for enrichment in clinical trials?
.
Alzheimer's & Dementia Diagnosis Assessment & Disease Monitoring
vol.
1
,
(
1
)
48
-
60
.
Wu D, Cerutti C, Lopez-Ramirez MA, Pryce G, King-Robson J, Simpson JE, van der Pol SM, Hirst MC et al.
(
2015
)
.
Brain Endothelial miR-146a Negatively Modulates T-Cell Adhesion through Repressing Multiple Targets to Inhibit NF-κB Activation
.
Cerebrovascular and Brain Metabolism Reviews
vol.
35
,
(
3
)
412
-
423
.
Biela A, Watkinson M, Meier UC, Baker D, Giovannoni G, Becer CR, Krause S
(
2015
)
.
Disposable MMP-9 sensor based on the degradation of peptide cross-linked hydrogel films using electrochemical impedance spectroscopy
.
Biosensors and Bioelectronics
vol.
68
,
660
-
667
.
Wu D, Cerutti C, Lopez-Ramirez MA, Pryce G, King-Robson J, Simpson JE, Van Der Pol SMA, Hirst MC et al.
(
2015
)
.
Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activation
.
Journal of Perinatology
vol.
35
,
(
3
)
412
-
423
.
Pryce G, Baker D
(
2015
)
.
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis
.
vol.
231
,
213
-
231
.
Vainchtein I, Vinet J, Al-Izki S, Pryce G, Grit C, Brouwer N, Amor S, Baker D et al.
(
2015
)
.
Microglia are involved in apoptotic clearance during chronic-relapsing EAE
.
GLIA
.
vol.
63
,
E353
-
E353
.
Baker D, Amor S
(
2015
)
.
Mouse models of multiple sclerosis: lost in translation?
.
Current Pharmaceutical Design
vol.
21
,
(
18
)
2440
-
2452
.
Ruz Maldonado I, Pingitore A, Liu B, Huang GC, Baker D, Bermudez-Silva FJ, Persaud SJ
(
2015
)
.
Stimulation of insulin secretion by cannabinoid ligands LH-21 and Abn-CBD in mouse and human islets: evaluation of the role of GPR55
.
DIABETOLOGIA
.
vol.
58
,
S86
-
S86
.
Giovannoni G, Baker D, Schmierer K
(
2015
)
.
The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?
.
Multiple Sclerosis and Related Disorders
vol.
4
,
(
1
)
3
-
5
.
Pryce G, Riddall DR, Selwood DL, Giovannoni G, Baker D
(
2014
)
.
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids
.
Journal of Neuroimmune Pharmacology
vol.
10
,
(
2
)
281
-
292
.
Von Kutzleben S, Pryce G, Chretien N, Turner M, Siders W, Baker D
(
2014
)
.
Inhibition of relapsing experimental autoimmune encephalomyelitis in Biozzi ABH mice using a mouse CD52-specific monoclonal antibody
.
Journal of Neuroimmunology
.
vol.
275
,
Giovannoni G, Baker D, Schmierer K
(
2014
)
.
Simvastatin in patients with progressive multiple sclerosis
.
Lancet
vol.
384
,
(
9947
)
Pakpoor J, Disanto G, Altmann DR, Pavitt S, Turner B, Calado-Marta M, Juliusson G, Baker D et al.
(
2014
)
.
CANCER RISK IN MULTIPLE SCLEROSIS PATIENTS TAKING CLADRIBINE
.
Journal of Neurology Neurosurgery & Psychiatry
.
vol.
85
,
e4
-
e4
.
Amor S, van der Star BJ, Bosca I, Raffel J, Gnanapavan S, Watchorn J, Kuhle J, Giovannoni G et al.
(
2014
)
.
Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis
.
Mult Scler
vol.
20
,
(
10
)
1355
-
1362
.
Graham DP, Rezai A, Baker D, Smith PA, Watts JF
(
2014
)
.
The development and scalability of a high strength, damage tolerant, hybrid joining scheme for composite–metal structures
.
Composites Part A Applied Science and Manufacturing
vol.
64
,
11
-
24
.
Napolitano A, Miller S, Nicholls AW, Baker D, Van Horn S
(
2014
)
.
Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus (PLoS ONE (2014) 9, 7 (e100778) DOI: 10.1371/journal.pone.0100778)
.
PLoS ONE
vol.
9
,
(
8
)
Woodhead J, Yang K, Brouwer K, Siler S, Stahl S, Ambroso J, Baker D, Watkins P et al.
(
2014
)
.
Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid–Mediated DILI
.
CPT Pharmacometrics & Systems Pharmacology
vol.
3
,
(
7
)
1
-
8
.
Napolitano A, Miller S, Nicholls AW, Baker D, Van Horn S, Thomas E, Rajpal D, Spivak A et al.
(
2014
)
.
Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus
.
PLoS ONE
vol.
9
,
(
7
)
Ashton NJ, Hye A, Baird A, Torres A, Covin A, Bazenet C, Tan‐Hehir C, Baker D et al.
(
2014
)
.
F5‐02‐02: DISTINCT BLOOD PROTEIN MARKERS ARE ASSOCIATED WITH GLOBAL AND REGIONAL BRAIN BETA‐AMYLOID DEPOSITION IN ALZHEIMER'S DISEASE
.
Alzheimer's & Dementia
vol.
10
,
(
4S_Part_5
)
p283
-
p283
.
Burnham SC, Ames D, Baker D, Bush AI, Cobiac L, Doecke J, Ellis KA, Faux NG et al.
(
2014
)
.
O2‐13‐06: PREDICTING ALZHEIMER'S DISEASE FROM A BLOOD‐BASED BIOMARKER PROFILE: RESULTS FROM AIPL AT 54 MONTHS
.
Alzheimer's & Dementia
vol.
10
,
(
4S_Part_3
)
p196
-
p196
.
Ashton NJ, Kiddle SJ, Thurfjell L, Graf J, Ward M, Baird AL, Hye A, Dobson RJ et al.
(
2014
)
.
P1‐166: DISTINCT BLOOD PROTEIN MARKERS ARE ASSOCIATED WITH BRAIN REGIONS OF EARLY AMYLOID DEPOSITION IN ALZHEIMER'S DISEASE
.
Alzheimer's & Dementia
vol.
10
,
(
4S_Part_9
)
p360
-
p361
.
Burnham S, Raghavan N, Wilson B, Baker D, Ropacki MT, Novak G, Ames D, Ellis KA et al.
(
2014
)
.
P2‐250: NOVEL STATISTICALLY‐DERIVED COMPOSITE MEASURES FOR ASSESSING THE EFFICACY OF DISEASE‐MODIFYING THERAPIES IN PRODROMAL AD TRIALS: AN AIPL STUDY
.
Alzheimer's & Dementia
vol.
10
,
(
4S_Part_14
)
p567
-
p567
.
Lopez-Ramirez MA, Wu D, Pryce G, Simpson JE, Reijerkerk A, King-Robson J, Kay O, de Vries HE et al.
(
2014
)
.
MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation
.
FASEB J
vol.
28
,
(
6
)
2551
-
2565
.
Browne L, Lidster K, Al-Izki S, Clutterbuck L, Posada C, Chan AWE, Riddall D, Garthwaite J et al.
(
2014
)
.
Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis
.
J Med Chem
vol.
57
,
(
7
)
2942
-
2952
.
Baker DJ, Richards G
(
2014
)
.
On the delivery of weather services and parallels for the development of operational forest carbon measurement, reporting and verification systems
.
Carbon Management
vol.
2
,
(
5
)
567
-
573
.
Baker DJ, Wilkinson GP, Atkinson AM, Jones HB, Coghlan M, Charles AD, Leighton B
(
2014
)
.
Durable efficacy of GKAs in rodent models of T2D
.
British Journal of Pharmacology
vol.
171
,
(
7
)
1642
-
1654
.
Baker DJ, Atkinson AM, Wilkinson GP, Coope GJ, Charles AD, Leighton B
(
2014
)
.
Efficacy of antidiabetic agents in gkwt/del mice
.
British Journal of Pharmacology
vol.
171
,
(
7
)
1629
-
1641
.
Puentes F, Topping J, Kuhle J, van der Star BJ, Douiri A, Giovannoni G, Baker D, Amor S et al.
(
2014
)
.
Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis
.
J Neurol Neurosurg Psychiatry
vol.
85
,
(
3
)
274
-
278
.
Van Den Elsen PJ, Van Eggermond MCJA, Puentes F, Van Der Valk P, Baker D, Amor S
(
2014
)
.
The epigenetics of multiple sclerosis and other related disorders
.
Multiple Sclerosis and Related Disorders
vol.
3
,
(
2
)
163
-
175
.
Dua P, Warnes G, Chruch A, Martino D, Baker D, Giovannoni G, Meier UC
(
2014
)
.
Functional effects of anti-neuronal antibodies from patients with Tourette's syndrome and disorders associated with streptococcal infection
.
Neurology Psychiatry and Brain Research
vol.
20
,
(
1
)
17
-
18
.
Pakpoor J, Nyein S, Disanto G, Nwosu A, Baker D, Giovannoni G
(
2014
)
.
A global analysis of the use of social media to discuss multiple sclerosis
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
20
,
334
-
335
.
Baker D, Cazalaà J-B, Cousin M-T
(
2014
)
.
Aspects of the Development of Anesthesia in France
.
The Wondrous Story of Anesthesia
,
Springer Nature
Pryce G, Visintin C, Ramagopalan SV, Al-Izki S, De Faveri LE, Nuamah RA, Mein CA, Montpetit A et al.
(
2014
)
.
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists
.
FASEB J
vol.
28
,
(
1
)
117
-
130
.
Baker D, Amor S
(
2014
)
.
Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wisely
.
Multiple Sclerosis and Related Disorders
Whyte L, Khalid A, Finnie G, Chiu S, Baker D, Aspden R, Ross R
(
2014
)
.
GPR55 Regulates Peak Bone Mass and Steroid Hormone Levels in Male Mice
.
JOURNAL OF BONE AND MINERAL RESEARCH
.
vol.
29
,
S409
-
S409
.
Liu B, Song S, Baker D, Hassan Z, Drynda RL, Bowe JE, Jones PM, Persaud SJ
(
2014
)
.
GPR55 deletion is coupled to impaired insulin secretion and reduced islet cell turnover
.
DIABETIC MEDICINE
vol.
31
,
9
-
9
.
Baker D, Pell C, Donovan B
(
2014
)
.
HIV infection as a chronic disease: Optimising outcomes
.
Medicine Today
vol.
15
,
(
2
)
16
-
26
.
Amor S, Peferoen LAN, Vogel DYS, Breur M, van der Valk P, Baker D, Van Noort JM
(
2014
)
.
Inflammation in neurodegenerative diseases - an update
.
Immunology
vol.
142
,
(
2
)
151
-
166
.
Liu B, Song S, Baker D, Hassan Z, Drynda RL, Bowe JE, Jones PM, Persaud SJ
(
2014
)
.
Knockout of GPR55 impairs insulin secretion and reduces islet cell turnover
.
DIABETOLOGIA
vol.
57
,
S49
-
S49
.
Mullen L, Rigby A, Sclanders M, Adams G, Mittal G, Colston J, Fatah R, Subang C et al.
(
2014
)
.
Latency can be conferred to a variety of cytokines by fusion with latency-associated peptide from TGF-β
.
Expert Opin Drug Deliv
vol.
11
,
(
1
)
5
-
16
.
Mullen L, Adams G, Layward L, Vessillier S, Annenkov A, Mittal G, Rigby A, Sclanders M et al.
(
2014
)
.
Latent cytokines for targeted therapy of inflammatory disorders
.
Expert Opin Drug Deliv
vol.
11
,
(
1
)
101
-
110
.
Al-Izki S, Pryce G, Hankey DJR, Lidster K, von Kutzleben SM, Browne L, Clutterbuck L, Posada C et al.
(
2014
)
.
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis
.
Brain
vol.
137
,
(
Pt 1
)
92
-
108
.
Baker D, Pepper G, Yauner F, Giovannoni G
(
2014
)
.
MSer - A new, neutral descriptor for someone with multiple sclerosis
.
Multiple Sclerosis and Related Disorders
vol.
3
,
(
1
)
31
-
33
.
Song S, Liu B, Bowe JE, Baker D, Jones PM, Persaud SJ
(
2014
)
.
Specificity of GPR55 agonists and antagonist in the regulation of calcium handling and insulin secretion by mouse islets
.
DIABETIC MEDICINE
vol.
31
,
32
-
32
.
Baker D, Lidster K, Sottomayor A, Amor S
(
2014
)
.
Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies
.
PLoS Biol
vol.
12
,
(
1
)
Hampton DW, Serio A, Pryce G, Al-Izki S, Franklin RJ, Giovannoni G, Baker D, Chandran S
(
2013
)
.
Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis
.
Acta Neuropathologica Communications
vol.
1
,
(
1
)
Pryce G, Cabranes A, Fernández-Ruiz J, Bisogno T, Di Marzo V, Long JZ, Cravatt BF, Giovannoni G et al.
(
2013
)
.
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors
.
Mult Scler
vol.
19
,
(
14
)
1896
-
1904
.
Delarasse C, Smith P, Baker D, Amor S
(
2013
)
.
Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice
.
Immunology
vol.
140
,
(
4
)
456
-
464
.
Fishpool DT, Rezai A, Baker D, Ogin SL, Smith PA
(
2013
)
.
Interlaminar toughness characterisation of 3D woven carbon fibre composites
.
Plastics Rubber and Composites
vol.
42
,
(
3
)
108
-
114
.
James E, Dobson R, Kuhle J, Baker D, Giovannoni G, Ramagopalan SV
(
2013
)
.
The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis
.
Mult Scler
vol.
19
,
(
12
)
1571
-
1579
.
Puentes F, van der Star BJ, Victor M, Kipp M, Beyer C, Peferoen-Baert R, Ummenthum K, Pryce G et al.
(
2013
)
.
Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis
.
Journal of Neuroinflammation
vol.
10
,
Waite TD, Baker DJ, Murray V
(
2013
)
.
Marine Toxins
.
Essentials of Autopsy Practice
,
Springer Nature
Richter F, Baker D
(
2013
)
.
Computational protein design for synthetic biology
.
Synthetic Biology: Tools and Applications
,
Baker DJ, Murray VSG, Carli PA
(
2013
)
.
A pan-European study of capabilities to manage mass casualties from the release of chemical agents: the MASH project
.
Disaster Medicine
vol.
8
,
(
1
)
13
-
23
.
Baker D, Lidster K, Al-Izki S, Pryce G, Giovannoni G
(
2013
)
.
Animal models of progressive disability in MS
.
IRISH JOURNAL OF MEDICAL SCIENCE
vol.
182
,
S5
-
S6
.
Di Filippo M, Chiasserini D, Gardoni F, Viviani B, Tozzi A, Giampa C, Costa C, Tantucci M et al.
(
2013
)
.
Effects of central and peripheral inflammation on hippocampal synaptic plasticity
.
NEUROBIOLOGY OF DISEASE
vol.
52
,
229
-
236
.
Liu B, Song S, Baker D, Bowe J, Hassan Z, Drynda R, Jones P, Persaud S
(
2013
)
.
GPR55 deletion is coupled to impaired glucose tolerance and increased islet cell apoptosis
.
DIABETOLOGIA
.
vol.
56
,
S46
-
S46
.
Sisay S, Pryce G, Jackson SJ, Tanner C, Ross RA, Michael GJ, Selwood DL, Giovannoni G et al.
(
2013
)
.
Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis
.
PLoS One
vol.
8
,
(
10
)
Baker D, Pepper G, Yauner F, Giovannoni G
(
2013
)
.
MSer - A new, neutral descriptor for someone with multiple sclerosis
.
Multiple Sclerosis and Related Disorders
Lidster K, Jackson SJ, Ahmed Z, Munro P, Coffey P, Giovannoni G, Baker MD, Baker D
(
2013
)
.
Neuroprotection in a novel mouse model of multiple sclerosis
.
PLoS One
vol.
8
,
(
11
)
van den Elsen PJ, van Eggermond MCJA, Puentes F, van der Valk P, Baker D, Amor S
(
2013
)
.
The epigenetics of multiple sclerosis and other related disorders
.
Multiple Sclerosis and Related Disorders
Khoury GA, Liwo A, Khatib F, Zhou H, Chopra G, Bacardit J, Bortot LO, Faccioli RA et al.
(
2013
)
.
Wefold: A collaborative protein structure prediction experiment
.
Computational Molecular Science and Engineering Forum 2013 - Core Programming Area at the 2013 AIChE Annual Meeting: Global Challenges for Engineering a Sustainable Future
.
182
-
184
.
Baker DJ
(
2012
)
.
Cloudy Forecast for Weather Satellite Data
.
Science
vol.
338
,
(
6113
)
1419
-
1419
.
Baker D, Lidster K, Sottomayor A, Amor S
(
2012
)
.
Reproducibility: Research-reporting standards fall short
.
Nature
vol.
492
,
(
7427
)
Baker D, Lidster K, Sottomayor A, Amor S
(
2012
)
.
Research-reporting standards fall short
.
Nature
vol.
492
,
(
7427
)
41
-
41
.
Malich G, Coupland R, Donnelly S, Baker D
(
2012
)
.
A proposal for field-level medical assistance in an international humanitarian response to chemical, biological, radiological or nuclear events
.
Emergency Medicine Journal
vol.
30
,
(
10
)
Baker D, Amor S
(
2012
)
.
Multiple sclerosis - from bench to bedside
.
CNS Neurol Disord Drug Targets
vol.
11
,
(
5
)
495
-
496
.
Lidster K, Baker D
(
2012
)
.
Optical coherence tomography detection of neurodegeneration in multiple sclerosis
.
CNS Neurol Disord Drug Targets
vol.
11
,
(
5
)
518
-
527
.
Pryce G, Baker D
(
2012
)
.
Potential control of multiple sclerosis by cannabis and the endocannabinoid system
.
CNS Neurol Disord Drug Targets
vol.
11
,
(
5
)
624
-
641
.
Finlay SE, Earby M, Baker DJ, Murray VSG
(
2012
)
.
Explosions and Human Health: The Long-Term Effects of Blast Injury
.
Prehospital and Disaster Medicine
vol.
27
,
(
4
)
385
-
391
.
Amor S, Baker D
(
2012
)
.
Checklist for reporting and reviewing studies of experimental animal models of multiple sclerosis and related disorders
.
Multiple Sclerosis and Related Disorders
vol.
1
,
(
3
)
111
-
115
.
Baker D
(
2012
)
.
Civilian Exposure to Toxic Agents: Emergency Medical Response
.
Prehospital and Disaster Medicine
vol.
19
,
(
2
)
174
-
178
.
Clarke SFJ, Chilcott RP, Wilson JC, Kamanyire R, Baker DJ, Hallett A
(
2012
)
.
Decontamination of Multiple Casualties Who Are Chemically Contaminated: A Challenge for Acute Hospitals
.
Prehospital and Disaster Medicine
vol.
23
,
(
2
)
175
-
181
.
Baker D
(
2012
)
.
Improving Decontamination Procedures: A Priority for Chemical Incident Management
.
Prehospital and Disaster Medicine
vol.
25
,
(
5
)
440
-
441
.
Baker DJ, Jones KA, Mobbs SF, Sepai O, Morgan D, Murray VSG
(
2012
)
.
Safe Management of Mass Fatalities following Chemical, Biological, and Radiological Incidents
.
Prehospital and Disaster Medicine
vol.
24
,
(
3
)
180
-
188
.
Carli P, Telion C, Baker D
(
2012
)
.
Terrorism in France
.
Prehospital and Disaster Medicine
vol.
18
,
(
2
)
92
-
99
.
Gnanapavan S, Grant D, Pryce G, Jackson S, Baker D, Giovannoni G
(
2012
)
.
Neurofilament a biomarker of neurodegeneration in autoimmune encephalomyelitis
.
Autoimmunity
vol.
45
,
(
4
)
298
-
303
.
Baker D, Pryce G, Jackson SJ, Bolton C, Giovannoni G
(
2012
)
.
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis
.
Multiple Sclerosis and Related Disorders
vol.
1
,
(
2
)
64
-
75
.
Dua P, Meier UC, Baker D, Giovannoni G
(
2012
)
.
Functional effects of anti-neuronal antibodies in patients with encephalitis lethargica and other related disorders associated with streptococcal infection
.
Neurology Psychiatry and Brain Research
vol.
18
,
(
2
)
Baker D, Amor S
(
2012
)
.
Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis
.
J Neuroimmunol
vol.
242
,
(
1-2
)
78
-
83
.
van der Star BJ, Vogel DYS, Kipp M, Puentes F, Baker D, Amor S
(
2012
)
.
<i>In Vitro</i> and <i>In Vivo</i> Models of Multiple Sclerosis
.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
vol.
11
,
(
5
)
570
-
588
.
Lopez-Ramirez MA, Wu D, Pryce G, Simpson JE, Reijerkerk A, King-Robson J, de Vries HE, Hirst MC et al.
(
2012
)
.
Endothelial miR-155 promotes blood brain barrier dysfunction in neuroinflammation
.
JOURNAL OF NEUROIMMUNOLOGY
.
vol.
253
,
3
-
4
.
Kipp M, Van Der Star B, Vogel DYS, Puentes F, Van Der Valk P, Baker D, Amor S
(
2012
)
.
Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond
.
Multiple Sclerosis and Related Disorders
vol.
1
,
(
1
)
15
-
28
.
Finlay SE, Moffat A, Gazzard R, Baker D, Murray V
(
2012
)
.
Health Impacts of Wildfires
.
PLOS Currents
vol.
4
,
(
Disasters
)
Sher F, Amor S, Gerritsen W, Baker D, Jackson SL, Boddeke E, Copray S
(
2012
)
.
Intraventricularly Injected Olig2-NSCs Attenuate Established Relapsing-Remitting EAE in Mice
.
CELL TRANSPLANTATION
vol.
21
,
(
9
)
1883
-
1897
.
Song S, Liu B, Baker D, Huang GC, Amiel SA, King AJ, Bowe JE, Jones PM et al.
(
2012
)
.
Islet GPR55 is coupled to increased insulin secretion and decreased apoptosis
.
DIABETOLOGIA
vol.
55
,
S163
-
S163
.
van Noort JM, Baker D, Amor S
(
2012
)
.
Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors
.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
vol.
11
,
(
5
)
556
-
569
.
van der Star B, Puentes F, Gerritsen W, Huizinga R, Reijerkerk A, van der Valk P, Baker D, Amor S
(
2012
)
.
Neuronal specific T cells are pathogenic in Biozzi mice - Implications for MS
.
JOURNAL OF NEUROIMMUNOLOGY
.
vol.
253
,
155
-
155
.
Li C, Bowe JE, Baker D, Jones PM, Persaud SJ
(
2012
)
.
PS 014 Beta cell GPCRs and other signalling mechanisms
.
DIABETOLOGIA
vol.
55
,
S163
-
S163
.
Al-Izki S, Pryce G, O'Neill JK, Butter C, Giovannoni G, Amor S, Baker D
(
2012
)
.
Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse
.
Multiple Sclerosis and Related Disorders
vol.
1
,
(
1
)
29
-
38
.
Fox RJ, Thompson A, Baker D, Baneke P, Brown D, Browne P, Chandraratna D, Ciccarelli O et al.
(
2012
)
.
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS
.
MULTIPLE SCLEROSIS JOURNAL
vol.
18
,
(
11
)
1534
-
1540
.
Ayoub SS, Pryce G, Seed MP, Bolton C, Flower RJ, Baker D
(
2011
)
.
Paracetamol-induced hypothermia is independent of cannabinoids and transient receptor potential vanilloid-1 and is not mediated by AM404
.
Drug Metab Dispos
vol.
39
,
(
9
)
1689
-
1695
.
Al-Izki S, Pryce G, Jackson SJ, Giovannoni G, Baker D
(
2011
)
.
Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis
.
Mult Scler
vol.
17
,
(
8
)
939
-
948
.
Jackson SJ, Giovannoni G, Baker D
(
2011
)
.
Fingolimod modulates microglial activation to augment markers of remyelination
.
J Neuroinflammation
vol.
8
,
Baker D, Gerritsen W, Rundle J, Amor S
(
2011
)
.
Critical appraisal of animal models of multiple sclerosis
.
Mult Scler
vol.
17
,
(
6
)
647
-
657
.
Graham DP, Rezai A, Baker D, Smith PA, Watts JF
(
2011
)
.
A hybrid joining scheme for high strength multimaterial joints
.
ICCM International Conferences on Composite Materials
.
Puentes F, van der Star B, Huizinga R, Gerritsen W, van der Valk P, Baker D, Amor S
(
2011
)
.
Autoimmunity to axonal proteins in multiple sclerosis
.
MULTIPLE SCLEROSIS JOURNAL
vol.
17
,
S329
-
S329
.
Andreou AP, Supronsinchai W, Lasalandra M, Baker D, Goadsby PJ
(
2011
)
.
Cannabinoid mechanisms of acetaminophen within the trigeminal thalamus
.
CEPHALALGIA
.
vol.
31
,
8
-
8
.
Baker DJ, Nurok M
(
2011
)
.
Chemical and biologic warfare agents: An introduction for anesthesiologists
.
Essential Clinical Anesthesia
,
Jackson S, Giovannoni G, Baker D
(
2011
)
.
Fingolimod (FTY720) modulates microglial activation to augment markers of remyelination
.
MULTIPLE SCLEROSIS JOURNAL
vol.
17
,
S210
-
S210
.
Lidster K, Jackson S, Coffey P, Baker M, Garthwaite J, Selwood D, Giovannoni G, Baker D
(
2011
)
.
Neuroprotection in a novel optic neuritis model
.
MULTIPLE SCLEROSIS JOURNAL
vol.
17
,
S435
-
S435
.
Fishpool DT, Rezai A, Baker D, Ogin SL, Smith PA
(
2011
)
.
Preferential energy absorbing interfacesfor ballistic and structural applications
.
ICCM International Conferences on Composite Materials
.
Al-Izki S, Pryce G, Amor S, Gerritsen W, Garthwaite J, Giovannoni G, Selwood DL, Baker D
(
2011
)
.
Selective targeting of neuroprotection to MS lesions: sodium channel blockers in experimental autoimmune encephalomyelitis
.
MULTIPLE SCLEROSIS JOURNAL
vol.
17
,
S209
-
S210
.
Pryce G, Visintin C, Lutz B, Marsicano G, Giovannoni G, Selwood DL, Baker D
(
2011
)
.
Selective targeting of spasticity by CNS-excluded cannabinoids
.
MULTIPLE SCLEROSIS JOURNAL
vol.
17
,
S247
-
S247
.
Baker D, Pryce G, Visintin C, Pertwee RG, Tanner C, Ross R, Irving A, Sisay S et al.
(
2011
)
.
VSN16R a novel agent for the control of spasticity
.
MULTIPLE SCLEROSIS JOURNAL
vol.
17
,
S243
-
S243
.
Baker D, Amor S
(
2010
)
.
Editorial: Quality control of experimental autoimmune encephalomyelitis
.
Multiple Sclerosis
vol.
16
,
(
9
)
1025
-
1027
.
Baker D, Amor S
(
2010
)
.
Quality control of experimental autoimmune encephalomyelitis
.
Mult Scler
vol.
16
,
(
9
)
1025
-
1027
.
Baker DJ, Richards G, Grainger A, Gonzalez P, Brown S, DeFries R, Held A, Kellndorfer J et al.
(
2010
)
.
Achieving forest carbon information with higher certainty: A five-part plan
.
Environmental Science & Policy
vol.
13
,
(
3
)
249
-
260
.
Amor S, Puentes F, Baker D, van der Valk P
(
2010
)
.
Inflammation in neurodegenerative diseases
.
IMMUNOLOGY
vol.
129
,
(
2
)
154
-
169
.
Lapa e Silva JR, Pretolani M, Bachelet CM, Baker D, Scheper R, Vargaftig BB
(
2009
)
.
Booster-Dependent Alterations of the Subsets of T Lymphocytes and Eosinophils in the Bronchi of Immunized Guinea Pigs
.
International Archives of Allergy and Immunology
vol.
99
,
(
2-4
)
350
-
353
.
Goto K, Kawanabe K, Kowalski R, Baker D, Nakamura T
(
2009
)
.
Bonding ability evaluation of bone cement on the cortical surface of rabbit’s tibia
.
Journal of Materials Science: Materials in Medicine
vol.
21
,
(
1
)
139
-
146
.
Kimber I, Foster JR, Baker D, Turk JL
(
2009
)
.
Selective Impairment of T Lymphocyte Activation following Contact Sensitization with Oxazolone
.
International Archives of Allergy and Applied Immunology
vol.
95
,
(
2-3
)
142
-
148
.
Kimber I, Bentley AN, Ward RK, Baker D, Turk JL
(
2009
)
.
Antigen-Restricted Antigenic Competition Induced by 2,4-Dinitrochlorobenzene: Association with Depression of Lymphocyte Proliferation
.
International Archives of Allergy and Applied Immunology
vol.
91
,
(
3
)
315
-
322
.
Idris AI, Sophocleous A, Landao-Bassonga E, Canals M, Milligan G, Baker D, van't Hof RJ, Ralston SH
(
2009
)
.
Cannabinoid Receptor Type 1 Protects against Age-Related Osteoporosis by Regulating Osteoblast and Adipocyte Differentiation in Marrow Stromal Cells
.
CELL METAB
vol.
10
,
(
2
)
139
-
147
.
Healey DG, Baker D, Gschmeissner SE, Turk JL
(
2009
)
.
An Antigenic Determinant Common to Lymphocytes and Langerhans Cells of the Guinea Pig
.
International Archives of Allergy and Applied Immunology
vol.
82
,
(
2
)
120
-
124
.
Baker D, Healey DG, Verghese S, Schäfer H, Turk JL
(
2009
)
.
Phenotypic Analysis of Guinea Pig Langerhans Cells with Antibodies Directed against Leucocyte Surface Antigens
.
International Archives of Allergy and Applied Immunology
vol.
86
,
(
3
)
350
-
355
.
Al-Izki S, Pryce G, Giovannoni G, Baker D
(
2009
)
.
Evaluating potential therapies for bladder dysfunction in a mouse model of multiple sclerosis with high-resolution ultrasonography
.
Mult Scler
vol.
15
,
(
7
)
795
-
801
.
Idris AI, Sophocleous A, Landao-Bassonga E, Merkouris M, Milligan GI, Baker D, van't Hof RJ, Ralston SH
(
2009
)
.
Cannabinoid receptor type 1 protects against age-related bone loss by regulating osteoblast and adipocyte differentiation of bone marrow stromal cells
.
BONE
.
vol.
44
,
S222
-
S222
.
Hooper C, Pinteaux-Jones F, Fry VA, Sevastou IG, BAKER D, Heales SJ, Pocock JM
(
2009
)
.
Differential effects of albumin on microglia and macrophages; implications for neurodegeneration following blood-brain barrier damage
.
J Neurochem
vol.
109
,
(
3
)
694
-
705
.
Amor S, Baker D
(
2009
)
.
Experimental autoimmune encephalomyelitis
.
The Biology of Multiple Sclerosis
,
Gu H, Yi Q, Bray ST, Riddle DS, Baker D, Shiau AK
(
2008
)
.
A phage display system for studying the sequence determinants of protein folding
.
Protein Science
vol.
4
,
(
6
)
1108
-
1117
.
Rigby A, Baker D, Chernajovsky Y
(
2008
)
.
Targeting EPO to the CNS; development of a novel therapeutic strategy
.
IMMUNOLOGY
.
vol.
125
,
134
-
135
.
Mustafa I, Baker DJ
(
2008
)
.
Ventilator Care in the Developing World
.
Mechanical Ventilation: Clinical Applications and Pathophysiology
,
Baker DJ, Schaefer M, Kennel CF, Gibbons JH, Groat CG, Kennedy D, Rejeski D
(
2008
)
.
Response
.
Science
vol.
322
,
(
5903
)
855
-
856
.
Hampton DW, Anderson J, Pryce G, Irvine KA, Giovannoni G, Fawcett JW, Compston A, Franklin RJM et al.
(
2008
)
.
An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss
.
J NEUROIMMUNOL
vol.
201
,
200
-
211
.
Jackson S, Al-Izik S, Pryce G, Giovannoni G, Baker D
(
2008
)
.
Fingolimod reduces axonal loss in relapsing secondary progressive experimental autoimmune encephalomyelitis
.
MULTIPLE SCLEROSIS
.
vol.
14
,
S80
-
S81
.
Parkes H, Shorter S, So PW, Baker D, Pryce G, Giovannoni G, Schmierer K
(
2008
)
.
High resolution 1H nuclear magnetic resonance spectroscopic-based metabolomic urine analysis of experimental autoimmune encephalitis, a model disease of multiple sclerosis
.
MULTIPLE SCLEROSIS
.
vol.
14
,
S86
-
S87
.
Baker DJ, Wilson WS
(
2008
)
.
The Oceanography Society: Its Importance Then and Now
.
Oceanography
vol.
21
,
(
3
)
22
-
25
.
Al-Izki S, Pryce G, Jackson S, Giovannoni G, Baker D
(
2008
)
.
Neuroprotective effects of omega-3 fatty acids in a mouse model of multiple sclerosis
.
JOURNAL OF NEUROIMMUNOLOGY
.
vol.
197
,
173
-
173
.
Rigby A, Chernajovsky Y, Baker D
(
2008
)
.
Targeting EPO to the CNS; Development of a novel therapeutic strategy
.
JOURNAL OF NEUROIMMUNOLOGY
.
vol.
197
,
171
-
171
.
Schaefer M, Baker DJ, Gibbons JH, Groat CG, Kennedy D, Kennel CF, Rejeski D
(
2008
)
.
An Earth Systems Science Agency
.
Science
vol.
321
,
(
5885
)
44
-
45
.
Anderson JM, Hampton DW, Patani R, Pryce G, Crowther RA, Reynolds R, Franklin RJM, Giovannoni G et al.
(
2008
)
.
Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis
.
BRAIN
vol.
131
,
1736
-
1748
.
Pinteaux-Jones F, Sevastou IG, Fry VAH, Heales S, Baker D, Pocock JM
(
2008
)
.
Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors
.
J NEUROCHEM
vol.
106
,
(
1
)
442
-
454
.
BAKER D, O'NEILL JK, DAVISON AN, TURK JL
(
2008
)
.
Control of immune‐mediated disease of the central nervous system requires the use of a neuroactive agent: elucidation by the action of mitoxantrone
.
Clinical & Experimental Immunology
vol.
90
,
(
1
)
124
-
128
.
Betik AC, Baker DJ, Krause DJ, McConkey MJ, Hepple RT
(
2008
)
.
Exercise training in late middle‐aged male Fischer 344 × Brown Norway F1‐hybrid rats improves skeletal muscle aerobic function
.
Experimental Physiology
vol.
93
,
(
7
)
863
-
871
.
East E, Gverić D, Baker D, Pryce G, Lijnen HR, Cuzner ML
(
2008
)
.
Chronic relapsing experimental allergic encephalomyelitis (CREAE) in plasminogen activator inhibitor-1 knockout mice: the effect of fibrinolysis during neuroinflammation
.
Neuropathol Appl Neurobiol
vol.
34
,
(
2
)
216
-
230
.
Croxford JL, Pryce G, Jackson SJ, Ledent C, Giovannoni G, Pertwee RG, Yamamura T, Baker D
(
2008
)
.
Cannabinoid-mediated neuroprotection, not immuno suppression, may be more relevant to multiple sclerosis
.
J NEUROIMMUNOL
vol.
193
,
(
1-2
)
120
-
129
.
Pryce G, Jackson SJ, Baker D
(
2008
)
.
Cannabinoids for the Control of multiple Sclerosis
.
Cannabinoids and the Brain
,
Springer Nature
Baker D, Pryce G
(
2008
)
.
The endocannabinoid system and multiple sclerosis
.
Curr Pharm Des
vol.
14
,
(
23
)
2326
-
2336
.
(
2007
)
.
Correction for Barth et al., Toward high-resolution prediction and design of transmembrane helical protein structures
.
Proceedings of the National Academy of Sciences of the United States of America
vol.
104
,
(
51
)
20635
-
20635
.
Baker D, Jackson SJ, Pryce G
(
2007
)
.
Cannabinoid control of neuroinflammation related to multiple sclerosis
.
BRIT J PHARMACOL
vol.
152
,
(
5
)
649
-
654
.
Hoi PM, Visintin C, Okuyama M, Gardiner SM, Kaup SS, Bennett T, Baker D, Selwood DL et al.
(
2007
)
.
Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl) benzamide (VSN16) in the rat
.
BRIT J PHARMACOL
vol.
152
,
(
5
)
751
-
764
.
Pocock JM, Pinteaux-Jones F, Fry VA, Baker D, Heales SJ
(
2007
)
.
Metabotropic glutamate receptors on microglia: Switching off toxicity
.
JOURNAL OF NEUROCHEMISTRY
.
vol.
102
,
239
-
239
.
Baker DJ
(
2007
)
.
The Management of Casualties Following Toxic Agent Release: The Approach Adopted in France
.
Chemical Warfare Agents
,
Wiley
Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng XD et al.
(
2007
)
.
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
.
NAT MED
vol.
13
,
(
4
)
492
-
497
.
Baker DJ, Telion C, Carli P
(
2007
)
.
Multiple Casualty Incidents: The Prehospital Role of the Anesthesiologist in Europe
.
Anesthesiology Clinics
vol.
25
,
(
1
)
179
-
188
.
Pryce G, Baker D
(
2007
)
.
Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors
.
BRIT J PHARMACOL
vol.
150
,
(
4
)
519
-
525
.
Alverson K, Baker DJ
(
2006
)
.
Taking the Pulse of the Oceans
.
Science
vol.
314
,
(
5806
)
1657
-
1657
.
Baker DJ, Hepple RT
(
2006
)
.
Elevated caspase and AIF gene expression correlate with progression of sarcopenia during aging in male F344BN rats
.
Experimental Gerontology
vol.
41
,
(
11
)
1149
-
1156
.
Baker D, Croxford JL, Pryce G, Jackson SM, Ledent C, Marsicano G, Lutz B, Giovannoni G et al.
(
2006
)
.
Cannabinoid-mediated immunosuppression in experimental allergic encephalomyelitis
.
JOURNAL OF NEUROIMMUNOLOGY
.
vol.
178
,
90
-
91
.
Baker D
(
2006
)
.
Protection of axonal damage in experimental antoimmune encephalomyelitis
.
MULTIPLE SCLEROSIS
.
vol.
12
,
S12
-
S13
.
Baker D
(
2006
)
.
Role of immunity in neurodegeneration in autoimmune encephalomyelitis
.
JOURNAL OF NEUROIMMUNOLOGY
.
vol.
178
,
20
-
20
.
Cabranes A, Pryce G, Baker D, Fernandez-Ruiz J
(
2006
)
.
Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice
.
BRAIN RES
vol.
1107
,
199
-
205
.
Baker DJ, Betik AC, Krause DJ, Hepple RT
(
2006
)
.
No Decline in Skeletal Muscle Oxidative Capacity With Aging in Long-Term Calorically Restricted Rats: Effects Are Independent of Mitochondrial DNA Integrity
.
The Journals of Gerontology Series A
vol.
61
,
(
7
)
675
-
684
.
Hepple RT, Baker DJ, McConkey M, Murynka T, Norris R
(
2006
)
.
Caloric Restriction Protects Mitochondrial Function with Aging in Skeletal and Cardiac Muscles
.
Rejuvenation Research
.
vol.
9
,
219
-
222
.
Bio FAB Group, Baker D, Church G, Collins J, Endy D, Jacobson J, Keasling J, Modrich P et al.
(
2006
)
.
Engineering Life: Building a FAB for Biology
.
Scientific American
vol.
294
,
(
6
)
44
-
51
.
Bilsland LG, Dick JRT, Pryce G, Petrosino S, Di Marzo V, Baker D, Greensmith L
(
2006
)
.
Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice
.
FASEB J
vol.
20
,
(
7
)
1003
-
+
.
Baker DJ, Greenhaff PL, Timmons JA
(
2006
)
.
Glycogen phosphorylase inhibition as a therapeutic target: a review of the recent patent literature
.
Expert Opinion on Therapeutic Patents
vol.
16
,
(
4
)
459
-
466
.
Baker DJ, Krause DJ, Howlett RA, Hepple RT
(
2006
)
.
Nitric oxide synthase inhibition reduces O2 cost of force development and spares high‐energy phosphates following contractions in pump‐perfused rat hindlimb muscles
.
Experimental Physiology
vol.
91
,
(
3
)
581
-
589
.
Baker D, Pryce G, Croxford JL, Yamamura T
(
2006
)
.
Cannabinoid-mediated immunosuppression in experimental allergic encephalomyelitits
.
CURRENT TOPICS IN NEUROIMMUNOLOGY
.
Editors:
Tabira, T, Yamamura, T, Kira, J
,
109
-
116
.
Cristino L, De Petrocellis L, Pryce G, Baker D, Guglielmotti V, Di Marzo V
(
2006
)
.
Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain
.
NEUROSCIENCE
vol.
139
,
(
4
)
1405
-
1415
.
Baker D, Pryce G, Davies WL, Hiley CR
(
2006
)
.
In silico patent searching reveals a new cannabinoid receptor
.
TRENDS PHARMACOL SCI
vol.
27
,
(
1
)
1
-
4
.
Ligresti A, Cascio MG, Pryce G, Kulasegram S, Beletskaya I, De Petrocellis L, Saha B, Mahadevan A et al.
(
2006
)
.
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis
.
BRIT J PHARMACOL
vol.
147
,
(
1
)
83
-
91
.
Walker RC, Raman S, Baker D
(
2006
)
.
Poster reception---High resolution, high throughput protein structure prediction using IBM Blue Gene supercomputers
.
Conference:
Proceedings of the 2006 ACM/IEEE conference on Supercomputing - SC '06165
-
es
.
de Lago E, Fernandez-Ruiz J, Ortega-Gutierrez S, Cabranes A, Pryce G, Baker D, Lopez-Rodriguez M, Ramos JA
(
2006
)
.
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders
.
EUR NEUROPSYCHOPHARM
vol.
16
,
(
1
)
7
-
18
.
Preece NE, Amor S, Baker D, Gadian DG, O'Neill JK, Urenjak J
(
2005
)
.
Experimental encephalomyelitis modulates inositol and taurine in the spinal cord of biozzi mice
.
Magnetic Resonance in Medicine
vol.
32
,
(
6
)
692
-
697
.
Heijmans N, Smith PA, Morris-Downes MM, Pryce G, Baker D, Donaldson AVJ, 't Hart B, Amor S
(
2005
)
.
Encephalitogenic and tolerogenic potential of altered peptide ligands of MOG and PLP in Biozzi ABH mice
.
J NEUROIMMUNOL
vol.
167
,
(
1-2
)
23
-
33
.
Baker DJ, Hepple RT
(
2005
)
.
The Versatility of the Pump-Perfused Rat Hindlimb Preparation: Examples Relating to Skeletal Muscle Function and Energy Metabolism
.
Applied Physiology Nutrition and Metabolism
.
vol.
30
,
576
-
590
.
Baker D, Cazalaà J-B, Carli P
(
2005
)
.
Larrey and Percy—A tale of two Barons
.
Resuscitation
vol.
66
,
(
3
)
259
-
262
.
Carli P, Baker DJ
(
2005
)
.
Managing mass casualties following toxic agent release
.
International Journal of Intensive Care
vol.
12
,
(
3
)
East E, Baker D, Pryce G, Lijnen HR, Cuzner ML, Gverić D
(
2005
)
.
A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis
.
Am J Pathol
vol.
167
,
(
2
)
545
-
554
.
Pryce G, O'Neill JK, Croxford JL, Amor S, Hankey DJ, East E, Giovannoni G, Baker D
(
2005
)
.
Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis
.
J NEUROIMMUNOL
vol.
165
,
(
1-2
)
41
-
52
.
Amor S, Smith PA, 't Hart B, Baker D
(
2005
)
.
Biozzi mice: Of mice and human neurological diseases
.
J NEUROIMMUNOL
vol.
165
,
(
1-2
)
1
-
10
.
Baker DJ
(
2005
)
.
The French prehospital emergency medicine system (SAMU): An introduction
.
CPD Anaesthesia
vol.
7
,
(
1
)
20
-
25
.
Smith PA, Morris-Downes M, Heijmans N, Pryce G, Arter E, O'Neill JK, 't Hart B, Baker D et al.
(
2005
)
.
Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice
.
J NEUROIMMUNOL
vol.
164
,
(
1-2
)
76
-
84
.
Idris AI, Hof RJV, Greig IR, Ridge SA, Baker D, Ross RA, Ralston SH
(
2005
)
.
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
.
NAT MED
vol.
11
,
(
7
)
774
-
779
.
Jackson SJ, Diemel LT, Pryce G, Baker D
(
2005
)
.
Cannabinoids and neuroprotection in CNS inflammatory disease
.
JOURNAL OF THE NEUROLOGICAL SCIENCES
.
vol.
233
,
21
-
25
.
Hepple RT, Baker DJ, Kaczor JJ, Krause DJ
(
2005
)
.
Long‐term caloric restriction abrogates the age‐related decline in skeletal muscle aerobic function
.
The FASEB Journal
vol.
19
,
(
10
)
1320
-
1322
.
Idris AI, Van't Hof RJ, Greig IR, Ridge SA, Baker D, Ross RA, Ralston SH
(
2005
)
.
Cannabinoid receptor 1 knockout mice have increased bone mass and are protected from ovariectomy-induced bone loss
.
BONE
.
vol.
36
,
S132
-
S132
.
Pryce G, Baker D
(
2005
)
.
Emerging properties of cannabinoid medicines in management of multiple sclerosis
.
TRENDS NEUROSCI
vol.
28
,
(
5
)
272
-
276
.
Visintin C, Aliev AE, Riddall D, Baker D, Okuyama M, Hoi PM, Hiley R, Selwood DL
(
2005
)
.
Membrane receptor probes: Solid-phase synthesis of biotin-Asp-PEG-arvanil derivatives
.
ORG LETT
vol.
7
,
(
9
)
1699
-
1702
.
Baker D
(
2005
)
.
The problem of secondary contamination following chemical agent release
.
Critical Care
vol.
9
,
(
4
)
Gegg ME, Harry R, Hankey D, Zambarakji H, Pryce G, Baker D, Adamson P, Calder V et al.
(
2005
)
.
Suppression of autoimmune retinal disease by lovastatin does not require Th2 cytokine induction
.
J IMMUNOL
vol.
174
,
(
4
)
2327
-
2335
.
Jackson SJ, Pryce G, Diemel LT, Cuzner ML, Baker D
(
2005
)
.
Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation
.
NEUROSCIENCE
vol.
134
,
(
1
)
261
-
268
.
Baker DJ
(
2005
)
.
Critical care requirements after mass toxic agent release
.
Critical Care Medicine
vol.
33
,
(
1
)
s66
-
s74
.
Constantinescu CS, Baker D
(
2005
)
.
Cytokines in Experimental Autoimmune Encephalomyelitis
.
Experimental Models of Multiple Sclerosis
,
Springer Nature
Liu CZ, Green SM, Watkins ND, Baker D, McCaskie AW
(
2005
)
.
Dynamic creep and mechanical characteristics of SmartSet GHV bone cement
.
Journal of Materials Science: Materials in Medicine
vol.
16
,
(
2
)
153
-
160
.
Baker D
(
2005
)
.
Genetics of Experimental Allergic Encephalomyelitis
.
Experimental Models of Multiple Sclerosis
,
Springer Nature
Jackson SJ, Baker D, Cuzner ML, Diemel LT
(
2004
)
.
Cannabinoid-mediated neuroprotection following interferon-gamma treatment in a three-dimensional mouse brain aggregate cell culture
.
EUR J NEUROSCI
vol.
20
,
(
9
)
2267
-
2275
.
Hagen JL, Krause DJ, Baker DJ, Fu MH, Tarnopolsky MA, Hepple RT
(
2004
)
.
Skeletal Muscle Aging in F344BN F1-Hybrid Rats: I. Mitochondrial Dysfunction Contributes to the Age-Associated Reduction in VO2max
.
The Journals of Gerontology Series A
vol.
59
,
(
11
)
1099
-
1110
.
Hepple RT, Hagen JL, Krause DJ, Baker DJ
(
2004
)
.
Skeletal Muscle Aging in F344BN F1-Hybrid Rats: II. Improved Contractile Economy in Senescence Helps Compensate for Reduced ATP-Generating Capacity
.
The Journals of Gerontology Series A
vol.
59
,
(
11
)
1111
-
1119
.
Idris AI, Van't Hof' RJ, Greig IR, Ridge SA, Baker D, Ross RA, Ralston SH
(
2004
)
.
Regulation of osteoclastic bone resorption and bone mass by the cannabinoid receptor 1 pathway
.
JOURNAL OF BONE AND MINERAL RESEARCH
.
vol.
19
,
S284
-
S284
.
Pryce G, Jackson SM, Hankey DRJ, Giovannoni G, Baker D
(
2004
)
.
Cannabinoids are neuroprotective: dissociation of true neuroprotection from protection secondary to immunosuppression
.
JOURNAL OF NEUROIMMUNOLOGY
.
vol.
154
,
78
-
78
.
Heijmans N, Smith P, Pryce D, Baker D, Morris-Downes M, Amor S
(
2004
)
.
Non-encephalitogenic single amino acid substitutions of MOG 8-21 and PLP 56-70 suppress relapsing EAE in ABH mice
.
JOURNAL OF NEUROIMMUNOLOGY
.
vol.
154
,
60
-
60
.
Baker D, Pryce G
(
2004
)
.
The potential role of the endocannabinoid system in the control of multiple scleorsis
.
Current Medicinal Chemistry - Central Nervous System Agents
vol.
4
,
(
3
)
195
-
202
.
East E, Baker D, Pryce G, Cuzner ML, Gveric D
(
2004
)
.
The role of plasminogen activators in experimental allergic encephalomyelitis: inflammation and axonal pathology
.
JOURNAL OF NEUROIMMUNOLOGY
.
vol.
154
,
167
-
167
.
Roques A, Browne M, Taylor A, New A, Baker D
(
2004
)
.
Quantitative measurement of the stresses induced during polymerisation of bone cement
.
Biomaterials
vol.
25
,
(
18
)
4415
-
4424
.
Ellmerich S, Takacs K, Mycko M, Waldner H, Wahid F, Boyton RJ, Smith PA, Amor S et al.
(
2004
)
.
Disease-related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis
.
EUR J IMMUNOL
vol.
34
,
(
7
)
1839
-
1848
.
de Lago E, Ligresti A, Ortar G, Morera E, Cabranes A, Pryce G, Bifulco M, Baker D et al.
(
2004
)
.
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake
.
EUR J PHARMACOL
vol.
484
,
(
2-3
)
249
-
257
.
Wilkinson JD, Whalley BJ, Baker D, Pryce G, Constanti A, Gibbons S, Williamson EM
(
2003
)
.
Medicinal cannabis: is Delta(9)-tetrahydrocannabinol necessary for all its effects?
.
J PHARM PHARMACOL
vol.
55
,
(
12
)
1687
-
1694
.
Pryce G, Ahmed Z, Hankey DJR, Jackson SJ, Croxford JL, Pocock JM, Ledent C, Petzold A et al.
(
2003
)
.
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
.
BRAIN
vol.
126
,
2191
-
2202
.
Craner MJ, Kataoka Y, Lo AC, Black JA, Baker D, Waxman SG
(
2003
)
.
Temporal course of upregulation of Na-v 1.8 in Purkinje neurons parallels the progression of clinical deficit in experimental allergic encephalomyelitis
.
J NEUROPATH EXP NEUR
vol.
62
,
(
9
)
968
-
975
.
East E, Baker D, Pryce GM, Cuzner ML, Gveric D
(
2003
)
.
The role of plasminogen activators in experimental allergic encephalomyelitis
.
GLIA
.
40
-
40
.
Ahmed Z, Baker D, Cuzner ML
(
2003
)
.
Interleukin-12 induces mild experimental allergic encephalomyelitis following local central nervous system injury in the Lewis rat
.
J NEUROIMMUNOL
vol.
140
,
(
1-2
)
109
-
117
.
Giovannoni G, Baker D
(
2003
)
.
Inflammatory disorders of the central nervous system
.
CURR OPIN NEUROL
vol.
16
,
(
3
)
347
-
350
.
Hall RJ, Hollis-Moffatt JE, Merriman ME, Green RA, Baker D, Merriman TR
(
2003
)
.
An autoimmune diabetes locus (Idd21) on mouse Chromosome 18
.
MAMM GENOME
vol.
14
,
(
5
)
335
-
339
.
Baker D, Hankey DJR
(
2003
)
.
Gene therapy in autoimmune, demyelinating disease of the central nervous system
.
GENE THER
vol.
10
,
(
10
)
844
-
853
.
Greenwood J, Walters CE, Pryce G, Kanuga N, Beraud E, Baker D, Adamson P
(
2003
)
.
Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis
.
FASEB J
vol.
17
,
(
8
)
905
-
907
.
Pryce G, Giovannoni G, Baker D
(
2003
)
.
Mifepristone or inhibition of 11 beta-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Delta(9)-tetrahydrocannabinol in mice
.
NEUROSCI LETT
vol.
341
,
(
2
)
164
-
166
.
Petzold A, Baker D, Pryce G, Keir G, Thompson EJ, Giovannoni G
(
2003
)
.
Quantification of neurodegeneration by measurement of brain-specific proteins
.
J NEUROIMMUNOL
vol.
138
,
(
1-2
)
45
-
48
.
Baker D, Pryce G, Giovannoni G, Thompson AJ
(
2003
)
.
The therapeutic potential of cannabis
.
LANCET NEUROL
vol.
2
,
(
5
)
291
-
298
.
Baker D, Pryce G
(
2003
)
.
The therapeutic potential of cannabis in multiple sclerosis
.
EXPERT OPIN INV DRUG
vol.
12
,
(
4
)
561
-
567
.
Craner MJ, Lo AC, Black JA, Baker D, Newcombe J, Cuzner ML, Waxman SG
(
2003
)
.
Annexin II/piII is up-regulated in Purkinje cells in EAE and MS
.
NEUROREPORT
vol.
14
,
(
4
)
555
-
558
.
Baker D, Adamson P, Greenwood J
(
2003
)
.
Potential of statins for the treatment of multiple sclerosis
.
LANCET NEUROL
vol.
2
,
(
1
)
9
-
10
.
Shirley P
(
2003
)
.
Treatment of biological and chemical casualties in the UK
.
British Journal of Anaesthesia
vol.
90
,
(
1
)
106
-
107
.
Ahmed Z, Doward AI, Pryce G, Taylor DL, Pocock JM, Leonard JP, Baker D, Cuzner ML
(
2002
)
.
A role for caspase-1 and-3 in the pathology of experimental allergic encephalomyelitis - Inflammation versus degeneration
.
AM J PATHOL
vol.
161
,
(
5
)
1577
-
1586
.
Hall RJ, Hollis-Moffat JE, Merriman ME, Bridges RJ, Green RA, Williams G, Baker D, Merriman TR
(
2002
)
.
An autoimmune diabetes locus (ldd21) on mouse chromosome 18
.
AMERICAN JOURNAL OF HUMAN GENETICS
.
vol.
71
,
446
-
446
.
Baker DJ
(
2002
)
.
Editorial I Management of casualties from terrorist chemical and biological attack: a key role for the anaesthetist
.
British Journal of Anaesthesia
vol.
89
,
(
2
)
211
-
214
.
Thompson AJ, Baker D
(
2002
)
.
Cannabinoids in MS - Potentially useful but not just yet!
.
NEUROLOGY
vol.
58
,
(
9
)
1323
-
1324
.
Walters CE, Pryce G, Hankey DJR, Sebti SM, Hamilton AD, Baker D, Greenwood J, Adamson P
(
2002
)
.
Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an animal model of multiple sclerosis
.
J IMMUNOL
vol.
168
,
(
8
)
4087
-
4094
.
Morris-Downes MM, Smith PA, Rundle JL, Piddlesden SJ, Baker D, Pham-Dinh D, Heijmans N, Amor S
(
2002
)
.
Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice
.
J NEUROIMMUNOL
vol.
125
,
(
1-2
)
114
-
124
.
Youssef F, Seifalian AM, Jagroop IA, Myint F, Baker D, Mikhailidis DP, Hamilton G
(
2002
)
.
The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT)dagger
.
EUR J VASC ENDOVASC
vol.
23
,
(
4
)
358
-
364
.
Brooks JW, Pryce G, Bisogno T, Jaggar SI, Hankey DJR, Brown P, Bridges D, Ledent C et al.
(
2002
)
.
Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1/CB2 receptors
.
EUR J PHARMACOL
vol.
439
,
(
1-3
)
83
-
92
.
Morris-Downes MM, McCormack K, Baker D, Sivaprasad D, Natkunarajah J, Amor S
(
2002
)
.
Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2 ',3 '-cyclic nucleotide 3 '-phosphodiesterase (CNPase) in ABH and SJL mice
.
J NEUROIMMUNOL
vol.
122
,
(
1-2
)
20
-
33
.
Gårdelöf B, Tillant D, Baker DJ
(
2001
)
.
Mechanical ventilation during transport of critically ill patients
.
International Journal of Intensive Care
vol.
8
,
(
3
)
178
-
179
.
O'Neill JW, Kim DE, Johnsen K, Baker D, Zhang KYJ
(
2001
)
.
Single-Site Mutations Induce 3D Domain Swapping in the B1 Domain of Protein L from Peptostreptococcus magnus
.
Structure
vol.
9
,
(
11
)
1017
-
1027
.
Hankey DJR, Nickerson JM, Donoso LA, Lightman SL, Baker D
(
2001
)
.
Experimental autoimmune uveoretinitis in mice (Biozzi ABH and NOD) expressing the autoimmune-associated H-2A(g7) molecule: identification of a uveitogenic epitope
.
J NEUROIMMUNOL
vol.
118
,
(
2
)
212
-
222
.
Ahmed Z, Gveric D, Pryce G, Baker D, Leonard JP, Cuzner ML, Diemel LT
(
2001
)
.
Myelin/axonal pathology in interleukin-12 induced serial relapses of experimental allergic encephalomyelitis in the Lewis rat
.
Am J Pathol
vol.
158
,
(
6
)
2127
-
2138
.
Croxford JL, Feldmann M, Chernajovsky Y, Baker D
(
2001
)
.
Different therapeutic outcomes in experimental allergic encephalomyelitis dependant upon the mode of delivery of IL-10: A comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system
.
J IMMUNOL
vol.
166
,
(
6
)
4124
-
4130
.
Reichel MB, Bainbridge J, Baker D, Thrasher AJ, Bhattacharya SS, Ali RR
(
2001
)
.
An immune response after intraocular administration of an adenoviral vector containing a beta galactosidase reporter gene slows retinal degeneration in the rd mouse
.
BRIT J OPHTHALMOL
vol.
85
,
(
3
)
341
-
344
.
Hankey DJR, Lightman SL, Baker D
(
2001
)
.
Interphotoreceptor retinoid binding protein peptide-induced uveitis in B10.RIII mice: Characterization of disease parameters and immunomodulation
.
EXP EYE RES
vol.
72
,
(
3
)
341
-
350
.
Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Makriyannis A, Khanolkar A, Layward L et al.
(
2001
)
.
Endocannabinoids control spasticity in a multiple sclerosis model
.
FASEB J
vol.
15
,
(
2
)
300
-
302
.
Baker DJ, Paschen HR
(
2001
)
.
Emergency management of injury from the release of toxic substances: Medical aspects of the HAZMAT system
.
Prehospital Trauma Care
,
Generini S, Matucci-Cerinic M, Partsch G, Stancikova M, Pignone A, Konttinen YT, Rovensky J, Baker DJ et al.
(
2001
)
.
Evidence for hyaluronan production in the air pouch model in rats
.
Clinical and Experimental Rheumatology
vol.
19
,
(
3
)
271
-
276
.
Moles TM, Baker DJ
(
2001
)
.
Toxic trauma
.
Prehospital and Disaster Medicine
vol.
16
,
(
2
)
78
-
80
.
Baker DJ
(
2000
)
.
Emergency ventilation
.
vol.
7
,
is.
4
,
pp.
229
-
232
.
Abstract:
java.sql.Clob
org.hibernate.engine.jdbc.WrappedClob
java.io.Serializable
,
Black JA, Dib-Hajj S, Baker D, Newcombe J, Cuzner ML, Waxman SG
(
2000
)
.
Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis
.
Proceedings of the National Academy of Sciences of the United States of America
vol.
97
,
(
21
)
11598
-
11602
.
Chernajovsky Y, Dreja H, Daly G, Annenkov A, Gould D, Adams G, Croxford JL, Baker D et al.
(
2000
)
.
Immuno- and genetic therapy in autoimmune diseases
.
Genes Immun
vol.
1
,
(
5
)
295
-
307
.
Baker D
(
2000
)
.
Reply: a sanguine approach to cannabis
.
Trends Pharmacol Sci
vol.
21
,
(
6
)
Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L
(
2000
)
.
Cannabinoids control spasticity and tremor in a multiple sclerosis model
.
Nature
vol.
404
,
(
6773
)
84
-
87
.
Croxford JL, Triantaphyllopoulos KA, Neve RM, Feldmann M, Chernajovsky Y, Baker D
(
2000
)
.
Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor
.
J Immunol
vol.
164
,
(
5
)
2776
-
2781
.
Thoua NM, van Noort JM, Baker D, Bose A, van Sechel AC, van Stipdonk MJB, Travers PJ, Amor S
(
2000
)
.
Encephalitogenic and immunogenic potential of the stress protein αB-crystallin in Biozzi ABH (H-2A<SUP>g7</SUP>) mice
.
JOURNAL OF NEUROIMMUNOLOGY
vol.
104
,
(
1
)
47
-
57
.
Tillan D, Baker DJ, Carli P
(
2000
)
.
Mechanical ventilation during transport of critically ill patients
.
International Journal of Intensive Care
vol.
7
,
(
1
)
59
-
60+62+64
.
Chernajovsky Y, Gould D, Annenkov A, Dreja H, Daly G, Rabinovich GA, Croxford L, Baker D et al.
(
1999
)
.
Immunotherapy of auto-immune diseases by gene transfer
.
Biochem Soc Trans
vol.
27
,
(
6
)
869
-
873
.
Carli P, Baker DJ
(
1999
)
.
Trauma
.
vol.
5
,
is.
6
,
Wolters Kluwer
Brennan FR, O'Neill JK, Allen SJ, Butter C, Nuki G, Baker D
(
1999
)
.
CD44 is involved in selective leucocyte extravasation during inflammatory central nervous system disease
.
Immunology
vol.
98
,
(
3
)
427
-
435
.
Moles TM, Baker DJ
(
1999
)
.
Clinical analogies for the management of toxic trauma
.
Resuscitation
.
vol.
42
,
117
-
124
.
Baker DJ
(
1999
)
.
Editorial
.
Resuscitation
vol.
42
,
(
2
)
101
-
102
.
Chernajovsky Y, Gould D, Annenkov A, Dreja H, Daly G, Rabinovich GA, Croxford L, Baker D et al.
(
1999
)
.
IMMUNOTHERAPY OF AUTOIMMUNE DISEASES BY GENE TRANSFER
.
Biochemical Society Transactions
vol.
27
,
(
5
)
a137
-
a137
.
Baker DJ
(
1999
)
.
Management of respiratory failure in toxic disasters
.
Resuscitation
.
vol.
42
,
125
-
131
.
Baker DJ
(
1999
)
.
The pre-hospital management of injury following mass toxic release; a comparison of military and civil approaches
.
Resuscitation
.
vol.
42
,
155
-
159
.
Croxford JL, O'Neill JK, Ali RR, Browne K, Byrnes AP, Dallman MJ, Wood MJ, Fedlmann M et al.
(
1998
)
.
Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis
.
Eur J Immunol
vol.
28
,
(
12
)
3904
-
3916
.
Croxford JL, Ali R, Byrnes A, Dallman M, Feldmann M, Baker D
(
1998
)
.
Adenoviral gene therapy of experimental allergic encephalomyelitis (EAE) with CTLA4-Ig
.
Journal of Neuroimmunology
vol.
90
,
(
1
)
Thoua N-M, van Noort J, van Sechel A, van Stipdonk M, Baker D, Amor S
(
1998
)
.
Encephalitogenicity of the stress protein α-Crystallin in biozzi ABH mice
.
Journal of Neuroimmunology
vol.
90
,
(
1
)
Croxford JL, Triantaphyllopolous K, Feldmann M, Chernajovsky Y, Baker D
(
1998
)
.
Gene therapy of experimental allergic encephalomyelitis (EAE) with dimeric TNF receptors using cells as biological pumps
.
Journal of Neuroimmunology
vol.
90
,
(
1
)
Cazalaà JB, Baker DJ
(
1998
)
.
Design flaw in continuous syringe pumps
.
Intensive Care Medicine
vol.
24
,
(
6
)
646
-
647
.
Croxford JL, Triantaphyllopoulos K, Podhajcer OL, Feldmann M, Baker D, Chernajovsky Y
(
1998
)
.
Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system
.
J Immunol
vol.
160
,
(
10
)
5181
-
5187
.
Baker D
(
1998
)
.
Medical management of HAZMAT victims in civilian practice
.
Trends in Anaesthesia and Critical Care
vol.
9
,
(
2
)
52
-
57
.
Chernajovsky Y, Annenkov A, Herman C, Triantaphyllopoulos K, Gould D, Dreja H, Moyes SP, Croxford JL et al.
(
1998
)
.
Gene therapy for rheumatoid arthritis. Theoretical considerations
.
Drugs and Aging
vol.
12
,
(
1
)
29
-
41
.
Triantaphyllopoulos KA, Croxford JL, Baker D, Chernajovsky Y
(
1998
)
.
Cloning and expression of murine IFNβ and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis
.
Gene Therapy
vol.
5
,
(
2
)
253
-
263
.
Ali RR, Reichel MB, Byrnes AP, Stephens CJ, Thrasher AJ, Baker D, Hunt DM, Bhattacharya SS
(
1998
)
.
Co-injection of adenovirus expressing CTLA4-Ig prolongs adenovirally mediated lacZ reporter gene expression in the mouse retina
.
GENE THERAPY
vol.
5
,
(
11
)
1561
-
1565
.
Reichel MB, Ali RR, Thrasher AJ, Hunt DM, Bhattacharya SS, Baker D
(
1998
)
.
Immune responses limit adenovirally mediated gene expression in the adult mouse eye
.
Gene Therapy
vol.
5
,
(
8
)
1038
-
1046
.
O'Neill JK, Baker D, Morris MM, Gschmeissner SE, Jenkins HG, Butt AM, Kirvell SL, Amor S
(
1998
)
.
Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: Demyelination and fast axonal transport changes in disease
.
JOURNAL OF NEUROIMMUNOLOGY
vol.
82
,
(
2
)
210
-
218
.
Reichet MB, All RR, Baker D, Byrnes AP, D'Esposito F, Kanuga N, Hunt DM, Bhattacharya SS
(
1997
)
.
Co-injection of adenovirus expressing CTLA4-IG prolongs adenovirally-mediated lacz reporter gene expression in the mouse retina
.
Investigative Ophthalmology and Visual Science
vol.
38
,
(
4
)
Thoua NM, van Noort JM, Morris MM, Baker D, Travers PJ, Amor S
(
1997
)
.
The heat shock protein αB-crystallin induces EAE in Blozzi ABH mice
.
Immunology Letters
vol.
56
,
Croxford JL, O'Neill JK, Baker D
(
1997
)
.
Polygenic control of experimental allergic encephalomyelitis in Biozzi ABH and BALB/c mice
.
J Neuroimmunol
vol.
74
,
(
1-2
)
205
-
211
.
Morris MM, Dyson H, Baker D, Harbige LS, Fazakerley JK, Amor S
(
1997
)
.
Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection
.
Journal of Neuroimmunology
vol.
74
,
(
1-2
)
185
-
197
.
Amor S, Baker D, Layward L, McCormack K, Van Noort JM
(
1997
)
.
Multiple sclerosis: Variants on a theme
.
Immunology Today
vol.
18
,
(
8
)
368
-
371
.
Bolton C, O’ Neill JK, Allen SJ, Baker D
(
1997
)
.
Regulation of Chronic Relapsing Experimental Allergic Encephalomyelitis by Endogenous and Exogenous Glucocorticoids
.
International Archives of Allergy and Immunology
vol.
114
,
(
1
)
74
-
80
.
Baker DJ
(
1996
)
.
Advanced life support for acute toxic injury (TOXALS™)
.
European Journal of Emergency Medicine
vol.
3
,
(
4
)
256
-
262
.
Amor S, O'Neill JK, Morris MM, Smith RM, Wraith DC, Groome N, Travers PJ, Baker D
(
1996
)
.
Encephalitogenic epitopes of myelin basic protein, proteolipid protein, and myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2A<sup>g7</sup>) mice share an amino acid motif
.
Journal of Immunology
vol.
156
,
(
8
)
3000
-
3008
.
Brennan FR, ONeill JK, Allen SJ, Mikecz K, Glant TT, Nuki G, Baker D
(
1996
)
.
Anti-CD44 antibody prevents and ameriolates chronic relapsing experimental allergic encephalomyelitis (CREAE) by inhibition leukocyte migration to the CNS
.
ARTHRITIS AND RHEUMATISM
vol.
39
,
(
9
)
625
-
625
.
Baker D, Rosenwasser OA, O'Neill JK, Turk JL
(
1995
)
.
Genetic analysis of experimental allergic encephalomyelitis in mice
.
Journal of Immunology
vol.
155
,
(
8
)
4046
-
4051
.
Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu JM, Baker D
(
1994
)
.
Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice
.
The Journal of Immunology
vol.
153
,
(
10
)
4349
-
4356
.
Lapa-e-Silva JR, Pretolani M, Bachelet CM, Baker D, Scheper RJ, Vargaftig BB
(
1994
)
.
Emergence of T-lymphocytes, eosinophils and dendritic cells in the bronchi of actively sensitized guinea pigs after antigenic challenge
.
Brazilian Journal of Medical and Biological Research
vol.
27
,
(
7
)
1653
-
1658
.
Baker D, Butler D, Scallon BJ, O'Neill JK, Turk JL, Feldmann M
(
1994
)
.
Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor‐immunoglobulin fusion proteins
.
European Journal of Immunology
vol.
24
,
(
9
)
2040
-
2048
.
Lapa e Silva JR, Bachelet C-M, Pretolani M, Baker D, Scheper RJ, Vargaftig BB
(
1993
)
.
Immunopathologic Alterations in the Bronchi of Immunized Guinea Pigs
.
American Journal of Respiratory Cell and Molecular Biology
vol.
9
,
(
1
)
44
-
53
.
Amor S, Baker D, Groome N, Turk JL
(
1993
)
.
Identification of a major encephalitogenic epitope of proteolipid protein (residues 56-70) for the induction of experimental allergic encephalomyelitis in Biozzi AB/H and nonobese diabetic mice
.
The Journal of Immunology
vol.
150
,
(
12
)
5666
-
5672
.
Fairchild S, Baker D, Turk JL
(
1993
)
.
Characterization of experimental allergic encephalomyelitis-susceptible, Biozzi AB/H (H-2dq1) mice which express H-2Anod: analysis of T-cell receptor expression and the detection of a deletion ligand encoded by Mtv-7
.
Immunology
vol.
78
,
(
2
)
260
-
265
.
Lapa e Silva J-R, Pretolani M, Bachelet C-M, Baker D, Shepper RJ, Vargaftig BB
(
1993
)
.
Immunohistochemical Characterization of T Lymphocytes and Eosinophils in the Bronchial Wall of Actively Sensitized Guinea Pigs
.
CHEST Journal
vol.
103
,
(
2
)
130s
-
132s
.
Liu GY, Baker D, Fairchild S, Figueroa F, Quartey-Papafio R, Tone M, Healey D, Cooke A et al.
(
1993
)
.
Complete characterization of the expressed immune response genes in Biozzi AB/H mice: structural and functional identity between AB/H and NOD A region molecules
.
Immunogenetics
vol.
37
,
(
4
)
296
-
300
.
O'Neill JK, Baker D, Davidson AN, Allen SJ, Butter C, Waldmann H, Turk JL
(
1993
)
.
Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies
.
Journal of Neuroimmunology
vol.
45
,
(
1-2
)
1
-
14
.
Preece NE, Baker D, Butter C, Gadian DG, Urenjak J
(
1993
)
.
Experimental allergic encephalomyelitis raises betaine levels in the spinal cord of strain 13 guinea-pigs
.
NMR Biomed
vol.
6
,
(
3
)
194
-
200
.
Allen SJ, Baker D, O’Neill JK, Davison AN, Turk JL
(
1993
)
.
Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the biozzi ab/h mouse
.
Cellular Immunology
vol.
146
,
(
2
)
335
-
350
.
O'Neill JK, Baker D, Turk JL
(
1992
)
.
Inhibition of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse
.
Journal of Neuroimmunology
vol.
41
,
(
2
)
177
-
187
.
O'Neill JK, Baker D, Davison AN, Maggon KK, Jaffee BD, Turk JL
(
1992
)
.
Therapy of chronic relapsing experimental allergic encephalomyelitis and the role of the blood-brain barrier: elucidation by the action of Brequinar sodium
.
Journal of Neuroimmunology
vol.
38
,
(
1-2
)
53
-
62
.
Baker D, Davison AN
(
1991
)
.
Mechanisms of immune-mediated demyelinating disease of the central nervous system
.
Neurochemical Research
vol.
16
,
(
9
)
1067
-
1072
.
Butter C, O'Neill JK, Baker D, Gschmeissner SE, Turk JL
(
1991
)
.
An immunoelectron microscopical study of the expression of class II major histocompatibility complex during chronic relapsing experimental allergic encephalomyelitis in Biozzi AB/H mice
.
J Neuroimmunol
vol.
33
,
(
1
)
37
-
42
.
Butter C, Baker D, O'Neill JK, Turk JL
(
1991
)
.
Mononuclear cell trafficking and plasma protein extravasation into the CNS during chronic relapsing experimental allergic encephalomyelitis in Biozzi AB/H mice
.
J Neurol Sci
vol.
104
,
(
1
)
9
-
12
.
Baker D, O'Neill JK, Turk JL
(
1991
)
.
Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis
.
Cellular Immunology
vol.
134
,
(
2
)
505
-
510
.
O'Neill JK, Butter C, Baker D, Gschmeissner SE, Kraal G, Butcher EC, Turk JL
(
1991
)
.
Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse
.
Immunology
vol.
72
,
(
4
)
520
-
525
.
Baker D, Kimber I, Ahmed K, Turk JL
(
1991
)
.
Antigen-specific and non-specific depression of proliferative responses induced during contact sensitivity in mice
.
International Journal of Experimental Pathology
vol.
72
,
(
1
)
55
-
65
.
Baker D, O'Neill JK, Amor S, Khamashta MA, Turk JL
(
1991
)
.
Inhibition of chronic relapsing experimental allergic encephalomyelitis in the mouse by the alkyl-lysophospholipid ET-18-OCH<inf>3</inf>
.
International Journal of Immunopharmacology
vol.
13
,
(
4
)
385
-
392
.
Watson CM, Davison AN, Baker D, O'Neill JK, Turk JL
(
1991
)
.
Suppression of demyelination by mitoxantrone
.
Int J Immunopharmacol
vol.
13
,
(
7
)
923
-
930
.
Wilcox CE, Ward AM, Evans A, Baker D, Rothlein R, Turk JL
(
1990
)
.
Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis
.
J Neuroimmunol
vol.
30
,
(
1
)
43
-
51
.
Baker D, O'Neill JK, Gschmeissner SE, Wilcox CE, Butter C, Turk JL
(
1990
)
.
Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice
.
Journal of Neuroimmunology
vol.
28
,
(
3
)
261
-
270
.
Schäfer H, Baker D, Thiele B, Burger R
(
1990
)
.
Structure, cellular distribution, and functional characteristics of the guinea pig leucocyte common antigen
.
Cellular Immunology
vol.
128
,
(
2
)
370
-
384
.
Kimber I, Cumberbatch M, Bentley AN, Baker D
(
1990
)
.
Requirements for antigenic competition in contact sensitivity
.
Journal of Clinical and Laboratory Immunology
vol.
32
,
(
2
)
67
-
72
.
Butter C, Healey DG, Baker D, Turk JL
(
1989
)
.
A quantitative immunocytochemical study of the infiltrating lymphocytes in the spinal cord of guinea pigs with chronic relapsing experimental allergic encephalomyelitis
.
J Neuroimmunol
vol.
25
,
(
2-3
)
169
-
176
.
Wilcox CE, Healey DG, Baker D, Willoughby DA, Turk JL
(
1989
)
.
Presentation of myelin basic protein by normal guinea-pig brain endothelial cells and its relevance to experimental allergic encephalomyelitis
.
Immunology
vol.
67
,
(
4
)
435
-
440
.
Wilcox CE, Baker D, Butter C, Willoughby DA, Turk JL
(
1989
)
.
Differential expression of guinea pig class II major histocompatibility complex antigens on vascular endothelial cells in vitro and in experimental allergic encephalomyelitis
.
Cell Immunol
vol.
120
,
(
1
)
82
-
91
.
Kimber I, Shepherd CJ, Mitchell JA, Turk JL, Baker D
(
1989
)
.
Regulation of lymphocyte proliferation in contact sensitivity: homeostatic mechanisms and a possible explanation of antigenic competition
.
Immunology
vol.
66
,
(
4
)
577
-
582
.
Baker D, Kimber I, Turk JL
(
1989
)
.
Antigen-specific regulation of T lymphocyte proliferative responses to contact-sensitizing chemicals in the guinea pig
.
Cellular Immunology
vol.
119
,
(
1
)
153
-
159
.
Kraal G, Shiamatey-Koolma R, Hoffer M, Baker D, Scheper R
(
1988
)
.
Histochemical identification of guinea-pig macrophages by monoclonal antibody MR-1
.
Immunology
vol.
65
,
(
4
)
523
-
528
.
Baker D, Parker D, Healey DG, Turk JL
(
1987
)
.
Induction of sensitization and tolerance in contact sensitivity with haptenated epidermal cells in the guinea-pig
.
Immunology
vol.
62
,
(
4
)
659
-
664
.
Antoniou AV, Baker D, El-Sady E, Turk JL, Tan BTG, Scheper RJ
(
1987
)
.
Identification and quantitation of the expression of T cell surface markers during the development of chronic relapsing experimental allergic encephalomyelitis (CREAE) in the guinea pig
.
Journal of Neuroimmunology
vol.
14
,
(
3
)
293
-
303
.
BAKER D, PARKER DD, TURK JL
(
1985
)
.
Effect of depletion of epidermal dendritic cells on the induction of contact sensitivity in the guinea‐pig
.
British Journal of Dermatology
vol.
113
,
(
3
)
285
-
294
.